<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml">

<head>

<meta charset="utf-8">
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />

<meta name="viewport" content="width=device-width, initial-scale=1">

<meta name="author" content="Michael C Sachs and Erin E Gabriel" />


<title>Introduction to Principal Surrogate Evaluation in R</title>



<style type="text/css">code{white-space: pre;}</style>
<style type="text/css">
div.sourceCode { overflow-x: auto; }
table.sourceCode, tr.sourceCode, td.lineNumbers, td.sourceCode {
  margin: 0; padding: 0; vertical-align: baseline; border: none; }
table.sourceCode { width: 100%; line-height: 100%; }
td.lineNumbers { text-align: right; padding-right: 4px; padding-left: 4px; color: #aaaaaa; border-right: 1px solid #aaaaaa; }
td.sourceCode { padding-left: 5px; }
code > span.kw { color: #007020; font-weight: bold; } /* Keyword */
code > span.dt { color: #902000; } /* DataType */
code > span.dv { color: #40a070; } /* DecVal */
code > span.bn { color: #40a070; } /* BaseN */
code > span.fl { color: #40a070; } /* Float */
code > span.ch { color: #4070a0; } /* Char */
code > span.st { color: #4070a0; } /* String */
code > span.co { color: #60a0b0; font-style: italic; } /* Comment */
code > span.ot { color: #007020; } /* Other */
code > span.al { color: #ff0000; font-weight: bold; } /* Alert */
code > span.fu { color: #06287e; } /* Function */
code > span.er { color: #ff0000; font-weight: bold; } /* Error */
code > span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */
code > span.cn { color: #880000; } /* Constant */
code > span.sc { color: #4070a0; } /* SpecialChar */
code > span.vs { color: #4070a0; } /* VerbatimString */
code > span.ss { color: #bb6688; } /* SpecialString */
code > span.im { } /* Import */
code > span.va { color: #19177c; } /* Variable */
code > span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code > span.op { color: #666666; } /* Operator */
code > span.bu { } /* BuiltIn */
code > span.ex { } /* Extension */
code > span.pp { color: #bc7a00; } /* Preprocessor */
code > span.at { color: #7d9029; } /* Attribute */
code > span.do { color: #ba2121; font-style: italic; } /* Documentation */
code > span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code > span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code > span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
</style>



<link href="data:text/css;charset=utf-8,body%20%7B%0Abackground%2Dcolor%3A%20%23fff%3B%0Amargin%3A%201em%20auto%3B%0Amax%2Dwidth%3A%20700px%3B%0Aoverflow%3A%20visible%3B%0Apadding%2Dleft%3A%202em%3B%0Apadding%2Dright%3A%202em%3B%0Afont%2Dfamily%3A%20%22Open%20Sans%22%2C%20%22Helvetica%20Neue%22%2C%20Helvetica%2C%20Arial%2C%20sans%2Dserif%3B%0Afont%2Dsize%3A%2014px%3B%0Aline%2Dheight%3A%201%2E35%3B%0A%7D%0A%23header%20%7B%0Atext%2Dalign%3A%20center%3B%0A%7D%0A%23TOC%20%7B%0Aclear%3A%20both%3B%0Amargin%3A%200%200%2010px%2010px%3B%0Apadding%3A%204px%3B%0Awidth%3A%20400px%3B%0Aborder%3A%201px%20solid%20%23CCCCCC%3B%0Aborder%2Dradius%3A%205px%3B%0Abackground%2Dcolor%3A%20%23f6f6f6%3B%0Afont%2Dsize%3A%2013px%3B%0Aline%2Dheight%3A%201%2E3%3B%0A%7D%0A%23TOC%20%2Etoctitle%20%7B%0Afont%2Dweight%3A%20bold%3B%0Afont%2Dsize%3A%2015px%3B%0Amargin%2Dleft%3A%205px%3B%0A%7D%0A%23TOC%20ul%20%7B%0Apadding%2Dleft%3A%2040px%3B%0Amargin%2Dleft%3A%20%2D1%2E5em%3B%0Amargin%2Dtop%3A%205px%3B%0Amargin%2Dbottom%3A%205px%3B%0A%7D%0A%23TOC%20ul%20ul%20%7B%0Amargin%2Dleft%3A%20%2D2em%3B%0A%7D%0A%23TOC%20li%20%7B%0Aline%2Dheight%3A%2016px%3B%0A%7D%0Atable%20%7B%0Amargin%3A%201em%20auto%3B%0Aborder%2Dwidth%3A%201px%3B%0Aborder%2Dcolor%3A%20%23DDDDDD%3B%0Aborder%2Dstyle%3A%20outset%3B%0Aborder%2Dcollapse%3A%20collapse%3B%0A%7D%0Atable%20th%20%7B%0Aborder%2Dwidth%3A%202px%3B%0Apadding%3A%205px%3B%0Aborder%2Dstyle%3A%20inset%3B%0A%7D%0Atable%20td%20%7B%0Aborder%2Dwidth%3A%201px%3B%0Aborder%2Dstyle%3A%20inset%3B%0Aline%2Dheight%3A%2018px%3B%0Apadding%3A%205px%205px%3B%0A%7D%0Atable%2C%20table%20th%2C%20table%20td%20%7B%0Aborder%2Dleft%2Dstyle%3A%20none%3B%0Aborder%2Dright%2Dstyle%3A%20none%3B%0A%7D%0Atable%20thead%2C%20table%20tr%2Eeven%20%7B%0Abackground%2Dcolor%3A%20%23f7f7f7%3B%0A%7D%0Ap%20%7B%0Amargin%3A%200%2E5em%200%3B%0A%7D%0Ablockquote%20%7B%0Abackground%2Dcolor%3A%20%23f6f6f6%3B%0Apadding%3A%200%2E25em%200%2E75em%3B%0A%7D%0Ahr%20%7B%0Aborder%2Dstyle%3A%20solid%3B%0Aborder%3A%20none%3B%0Aborder%2Dtop%3A%201px%20solid%20%23777%3B%0Amargin%3A%2028px%200%3B%0A%7D%0Adl%20%7B%0Amargin%2Dleft%3A%200%3B%0A%7D%0Adl%20dd%20%7B%0Amargin%2Dbottom%3A%2013px%3B%0Amargin%2Dleft%3A%2013px%3B%0A%7D%0Adl%20dt%20%7B%0Afont%2Dweight%3A%20bold%3B%0A%7D%0Aul%20%7B%0Amargin%2Dtop%3A%200%3B%0A%7D%0Aul%20li%20%7B%0Alist%2Dstyle%3A%20circle%20outside%3B%0A%7D%0Aul%20ul%20%7B%0Amargin%2Dbottom%3A%200%3B%0A%7D%0Apre%2C%20code%20%7B%0Abackground%2Dcolor%3A%20%23f7f7f7%3B%0Aborder%2Dradius%3A%203px%3B%0Acolor%3A%20%23333%3B%0Awhite%2Dspace%3A%20pre%2Dwrap%3B%20%0A%7D%0Apre%20%7B%0Aborder%2Dradius%3A%203px%3B%0Amargin%3A%205px%200px%2010px%200px%3B%0Apadding%3A%2010px%3B%0A%7D%0Apre%3Anot%28%5Bclass%5D%29%20%7B%0Abackground%2Dcolor%3A%20%23f7f7f7%3B%0A%7D%0Acode%20%7B%0Afont%2Dfamily%3A%20Consolas%2C%20Monaco%2C%20%27Courier%20New%27%2C%20monospace%3B%0Afont%2Dsize%3A%2085%25%3B%0A%7D%0Ap%20%3E%20code%2C%20li%20%3E%20code%20%7B%0Apadding%3A%202px%200px%3B%0A%7D%0Adiv%2Efigure%20%7B%0Atext%2Dalign%3A%20center%3B%0A%7D%0Aimg%20%7B%0Abackground%2Dcolor%3A%20%23FFFFFF%3B%0Apadding%3A%202px%3B%0Aborder%3A%201px%20solid%20%23DDDDDD%3B%0Aborder%2Dradius%3A%203px%3B%0Aborder%3A%201px%20solid%20%23CCCCCC%3B%0Amargin%3A%200%205px%3B%0A%7D%0Ah1%20%7B%0Amargin%2Dtop%3A%200%3B%0Afont%2Dsize%3A%2035px%3B%0Aline%2Dheight%3A%2040px%3B%0A%7D%0Ah2%20%7B%0Aborder%2Dbottom%3A%204px%20solid%20%23f7f7f7%3B%0Apadding%2Dtop%3A%2010px%3B%0Apadding%2Dbottom%3A%202px%3B%0Afont%2Dsize%3A%20145%25%3B%0A%7D%0Ah3%20%7B%0Aborder%2Dbottom%3A%202px%20solid%20%23f7f7f7%3B%0Apadding%2Dtop%3A%2010px%3B%0Afont%2Dsize%3A%20120%25%3B%0A%7D%0Ah4%20%7B%0Aborder%2Dbottom%3A%201px%20solid%20%23f7f7f7%3B%0Amargin%2Dleft%3A%208px%3B%0Afont%2Dsize%3A%20105%25%3B%0A%7D%0Ah5%2C%20h6%20%7B%0Aborder%2Dbottom%3A%201px%20solid%20%23ccc%3B%0Afont%2Dsize%3A%20105%25%3B%0A%7D%0Aa%20%7B%0Acolor%3A%20%230033dd%3B%0Atext%2Ddecoration%3A%20none%3B%0A%7D%0Aa%3Ahover%20%7B%0Acolor%3A%20%236666ff%3B%20%7D%0Aa%3Avisited%20%7B%0Acolor%3A%20%23800080%3B%20%7D%0Aa%3Avisited%3Ahover%20%7B%0Acolor%3A%20%23BB00BB%3B%20%7D%0Aa%5Bhref%5E%3D%22http%3A%22%5D%20%7B%0Atext%2Ddecoration%3A%20underline%3B%20%7D%0Aa%5Bhref%5E%3D%22https%3A%22%5D%20%7B%0Atext%2Ddecoration%3A%20underline%3B%20%7D%0A%0Acode%20%3E%20span%2Ekw%20%7B%20color%3A%20%23555%3B%20font%2Dweight%3A%20bold%3B%20%7D%20%0Acode%20%3E%20span%2Edt%20%7B%20color%3A%20%23902000%3B%20%7D%20%0Acode%20%3E%20span%2Edv%20%7B%20color%3A%20%2340a070%3B%20%7D%20%0Acode%20%3E%20span%2Ebn%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Efl%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Ech%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Est%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Eco%20%7B%20color%3A%20%23888888%3B%20font%2Dstyle%3A%20italic%3B%20%7D%20%0Acode%20%3E%20span%2Eot%20%7B%20color%3A%20%23007020%3B%20%7D%20%0Acode%20%3E%20span%2Eal%20%7B%20color%3A%20%23ff0000%3B%20font%2Dweight%3A%20bold%3B%20%7D%20%0Acode%20%3E%20span%2Efu%20%7B%20color%3A%20%23900%3B%20font%2Dweight%3A%20bold%3B%20%7D%20%20code%20%3E%20span%2Eer%20%7B%20color%3A%20%23a61717%3B%20background%2Dcolor%3A%20%23e3d2d2%3B%20%7D%20%0A" rel="stylesheet" type="text/css" />

</head>

<body>




<h1 class="title toc-ignore">Introduction to Principal Surrogate Evaluation in R</h1>
<h4 class="author"><em>Michael C Sachs and Erin E Gabriel</em></h4>
<h4 class="date"><em>augusti 01, 2016</em></h4>



<style type="text/css">
div.r-help-page {
  outline: #000000 solid thin;
}
</style>
<div id="methods" class="section level1">
<h1>Methods</h1>
<div id="introduction" class="section level2">
<h2>Introduction</h2>
<p>A valid principal surrogate endpoint can be used as a primary endpoint for evaluating treatments in phase II clinical trials and for predicting individual treatment effects post lincensure. A surrogate is considered to be valid if it provides reliable predictions of treatment effects on the clinical endpoint of interest. <span class="citation">Frangakis and Rubin (2002)</span> introduced the concept of principal stratification and the definition of a principal surrogate (PS). Informally, a post-treatment intermediate response variable is a principal surrogate if causal effects of the treatment on the clinical outcome only exist when causal effects of the treatment on the intermediate variable exist. The criteria for a PS have been modified and extended in more recent works, with most current literture focusing of wide effect modification as the primary criterion of interst; tests for wide effect modification are included in the package.</p>
<p>The goal of PS evaluation is estimation and testing of how treatment efficacy on the clinical outcome of interest varies over subgroups defined by possible treatment and surrogate combinations of interest; this is an effect modification objective. The combinations of interest are called the principal strata and they include a set of unobservable counterfactual responses: responses that would have occured under a set of condtions counter to the observed conditions. To finesse this problem of unobservable responses, a variety of clever trial designs and estimation approaches have been proposed. Several of these have been implemented in the <code>pseval</code> package.</p>
</div>
<div id="notation" class="section level2">
<h2>Notation</h2>
<p>Let <span class="math inline">\(Z_i\)</span> be the treatment indicator for subject <span class="math inline">\(i\)</span>, where 0 indicates the control or standard treatment, and 1 indicates the experimental treatment. We currently only allow for two levels of treatment and assume that the treatment assigments are randomized. Let <span class="math inline">\(S_i\)</span> be the observed value of the intermediate response for subject <span class="math inline">\(i\)</span>. Since <span class="math inline">\(S_i\)</span> can be affected by treatment, there are two naturally occuring counterfactual values of <span class="math inline">\(S_i\)</span>: <span class="math inline">\(S_i(1)\)</span> under treatment, and <span class="math inline">\(S_i(0)\)</span> under control. Let <span class="math inline">\(s_z\)</span> be the realization of the random variable <span class="math inline">\(S(z)\)</span>, for <span class="math inline">\(z \in \{0, 1\}\)</span>. The outcome of interest is denoted <span class="math inline">\(Y_i\)</span>. We consider the counterfactual values of <span class="math inline">\(Y_i(0)\)</span> and <span class="math inline">\(Y_i(1)\)</span>. We allow for both binary and time-to-event outcomes, thus <span class="math inline">\(Y_i\)</span> may be a vector containing a time variable and an event/censoring indicator, i.e. <span class="math inline">\(Y_i = (T_i, \Delta_i)\)</span> where <span class="math inline">\(\Delta_i = 1\)</span> if <span class="math inline">\(T_i\)</span> is an event time, and <span class="math inline">\(\Delta_i = 0\)</span> if <span class="math inline">\(T_i\)</span> is a censoring time. For all of the methods, <span class="math inline">\(S_i(z)\)</span> is only defined if the clinical outcome <span class="math inline">\(Y_i(z)\)</span> does not occur before the potential surrogate <span class="math inline">\(S_i(z)\)</span> is measured at a fixed time <span class="math inline">\(\tau\)</span> after entry into the study. The data analyses only include participants who have not experienced the clinical outcome by time <span class="math inline">\(\tau\)</span>. For validity all of the methods assume no individual-level treatment effects on <span class="math inline">\(Y\)</span> before <span class="math inline">\(\tau\)</span>, which we refer to as the ‘Equal early individual risk’ assumption below.</p>
</div>
<div id="estimands" class="section level2">
<h2>Estimands</h2>
<p>Criteria for <span class="math inline">\(S\)</span> to be a good surrogate are based on risk estimands that condition on the potential intermediate responses. The risk is defined as a mapping <span class="math inline">\(g\)</span> of the cumulative distribution function of <span class="math inline">\(Y(z)\)</span> conditional on the intermediate responses. Currently we focus only on marginal risk estimands which condition only on <span class="math inline">\(S(1)\)</span>, the intermediate response or biomarker under active treatment:</p>
<p><span class="math display">\[
risk_1(s_1) = g\left\{F_{s_1}\left[Y(1) | S(1) = s_1\right]\right\}, \\
risk_0(s_1) = g\left\{F_{s_1}\left[Y(0) | S(1) = s_1\right]\right\}.
\]</span></p>
<p>The joint risk estimands also condition on <span class="math inline">\(S(0)\)</span>, the intermediate response or biomarker under control. In the special case where <span class="math inline">\(S(0)\)</span> is constant, such as the immune response to HIV antigens in the placebo arm of a vaccine trial, the joint and marginal risk estimands are equivalent. This special case is referred to as case constant biomarker (CB) in much of the literature <span class="citation">(P. Gilbert and Hudgens 2008)</span>.</p>
<p>For instance, for a binary outcome, the risk function may simply be the probability <span class="math inline">\(risk_z(s_1) = P(Y(z) = 1 | S(1) = s_1)\)</span>, or for a time-to-event outcome the risk function may be the cumulative distribution function <span class="math inline">\(risk_z(s_1) = P(Y(z) \leq t | S(1) = s_1)\)</span>.</p>
<p>Specification of the distributions of <span class="math inline">\(Y(z) | S(1)\)</span> determines the likelihood, we will denote this as <span class="math inline">\(f(y | \beta, s_1, z)\)</span>. If <span class="math inline">\(S(1)\)</span> were fully observed, simple maximum likelihood estimation could be used. The key challenge in estimating these risk estimands is solving the problem of conditioning on counterfactual values that are not observable for at least a subset of subjects in a randomized trial. This involves integrating out missing values based on some models and/or set of assumptions. Namely, <span class="math inline">\(S(1)\)</span> is unobserved for all subjects who received treatment 0.</p>
</div>
<div id="prinicipal-surrogate-criteria" class="section level2">
<h2>Prinicipal Surrogate Criteria</h2>
<p><span class="citation">Frangakis and Rubin (2002)</span> gave a single criterion for a biomarker S to be a PS: causal effects of the treatment on the clinical outcome only exist when causal effects of the treatment on the intermediate variable exist. In general this can only be evaluated using the joint risk estimands, which consider not only the counterfacutal values of the biomarker under treatment, but also under control <span class="math inline">\(S(0)\)</span>. However, in the special case where all <span class="math inline">\(S(0)\)</span> values are constant, say at level <span class="math inline">\(C\)</span>, such as an immune response to HIV in a HIV negative population pre-vaccination this criteria, often referred to as average causal neccasity (ACN), can by written in terms of the marginal risk estimands as:</p>
<p><span class="math display">\[
  risk_1(C)=risk_0(C) 
\]</span></p>
<p>More recently, other works <span class="citation">P. Gilbert and Hudgens (2008)</span>, <span class="citation">J. Wolfson and Gilbert (2010)</span>, <span class="citation">Ying Huang, Gilbert, and Wolfson (2013)</span>, <span class="citation">Erin E. Gabriel and Gilbert (2014)</span>, and <span class="citation">Erin E Gabriel and Follmann (2015)</span> have suggested that this criterion is both too restrictive and in some cases can be vacuously true. Instead most current works suggest that the wide effect modification (WEM) criterion is of primary importance, ACN being of secondary importance. WEM is given formally in terms of the risk estimands and a known contrast function <span class="math inline">\(h\)</span> satisfying <span class="math inline">\(h(x, y) = 0\)</span> if and only if <span class="math inline">\(x = y\)</span> by:</p>
<p><span class="math display">\[
  |h(risk_1(s_1),risk_0(s_1)) - h(risk_1(s{_1}^*),risk_0(s{_1}^*))|&gt;\delta
\]</span></p>
<p>for at least some <span class="math inline">\(s_1 \neq s_{1}^*\)</span> and <span class="math inline">\(\delta&gt;0\)</span>, with the larger the <span class="math inline">\(\delta\)</span> the better. To evaluate WEM and ACN we need to identify the risk estimands.</p>
</div>
<div id="augmentation-and-assumptions" class="section level2">
<h2>Augmentation and Assumptions</h2>
<p>We first make three standard assumptions used in much of the literature for absorbing events outcomes:</p>
<ul>
<li>Stable Unit Treatment Value Assumption (SUTVA): Observations on the independent units in the trial should be unaffected by the treatment assignment of other units.</li>
<li>Ignorable Treatment Assignment: The observed treatment assignment does not change the counterfactual clinical outcome.</li>
<li>Equal individual risk up to the time of candidate surrogate measurement <span class="math inline">\(\tau\)</span>.</li>
</ul>
<p><span class="citation">J. Wolfson and Gilbert (2010)</span> outlines how these assumptions are needed for identification of the risk estimands. Now to deal with the missing <span class="math inline">\(S(1)\)</span> values among those with <span class="math inline">\(Z = 0\)</span>, we focus on three trial augmentations: Baseline immunogenicity predictor (BIP), closeout placebo vaccination (CPV), and baseline surrogate measurement (BSM). For details on these augmentations, we refer you to <span class="citation">D. Follmann (2006)</span>, <span class="citation">P. Gilbert and Hudgens (2008)</span>, <span class="citation">Erin E. Gabriel and Gilbert (2014)</span>, and <span class="citation">Erin E Gabriel and Follmann (2015)</span>.</p>
<p>In time-to-event settings one more assumption is needed: - Non-informative censoring.</p>
<p><em>It should be noted that the equal individual risk assumption requires that time-to-event analysis start at time <span class="math inline">\(\tau\)</span>, rather than at randomization.</em></p>
<div id="bip" class="section level3">
<h3>BIP</h3>
<p>Briefly, a BIP <span class="math inline">\(W\)</span> is any baseline measurement or set of measurements that is highly correlated with <span class="math inline">\(S\)</span>. It is particularly useful if <span class="math inline">\(W\)</span> is unlikely to be associated with the clinical outcome after conditioning on <span class="math inline">\(S\)</span>, i.e. <span class="math inline">\(Y \perp W | S(1)\)</span>; some of the methods leverage this assumption. The BIP <span class="math inline">\(W\)</span> is used to integrate out the missing <span class="math inline">\(S(1)\)</span> among those with <span class="math inline">\(Z = 0\)</span> based on a model for <span class="math inline">\(S(1) | W\)</span> that is estimated among those with <span class="math inline">\(Z = 1\)</span>. We describe how this model is used in the next section.</p>
<p>The assumptions needed for a BIP to be useful depend on the risk model used. If the BIP is included in the risk model, only the assumption of no interaction with treatment and the candidate surrogate are needed. However, if the BIP is not included in the risk model, the assumption that that clinical outcome is independent of the BIP given the candidate surrogate is needed. Although not a requirement for identification of the risk estimands, it has been found in most simulations studies that a correlation between the BIP and <span class="math inline">\(S(1)\)</span> of greater than 0.6 is needed for unbiased estimation in finite samples.</p>
</div>
<div id="cpv" class="section level3">
<h3>CPV</h3>
<p>Under a CPV augmented design, control recipients that do not have events at the end of the follow-up period are given the experimental treatment. Then their intermediate response is measured at some time post treatment. This measurement is then used as a direct imputation for the missing <span class="math inline">\(S(1)\)</span>. One set of conservative assumptions to use CPV as a direct imputation for <span class="math inline">\(S(1)\)</span> are given in <span class="citation">J. Wolfson and Gilbert (2010)</span> are:</p>
<ul>
<li>Time constancy of the true immune response under active treatment, <span class="math inline">\(S(1)=S_{CPV}\)</span> almost surely, for placebo recipients that are crossed over at the end of the trial</li>
<li>No infections during the close-out period</li>
</ul>
</div>
<div id="bsm" class="section level3">
<h3>BSM</h3>
<p><span class="citation">Erin E. Gabriel and Gilbert (2014)</span> suggested the baseline augmentation BSM, which is a pre-treatment measurement of the candidate PS, denoted <span class="math inline">\(S_B\)</span>. The BSM may be a good predictor of <span class="math inline">\(S(1)\)</span> without any further assumptions. It can be used in the same way as a BIP. Alternatively you can transform <span class="math inline">\(S(1) - S_B\)</span> and use this as the candidate surrogate, further increasing the assocation with the BSM/BIP. Under the BSM assumption outlined in <span class="citation">Erin E. Gabriel and Gilbert (2014)</span>;</p>
<ul>
<li>Time constancy of the true immune response under control,</li>
</ul>
<p>then <span class="math inline">\(S(0)=S_{BSM}\)</span> almost surely.</p>
</div>
</div>
<div id="estimated-maximum-likelihood" class="section level2">
<h2>Estimated Maximum Likelihood</h2>
<p>Let <span class="math inline">\(f(y | \beta, s_1, z)\)</span> denote the density of <span class="math inline">\(Y | S(1), Z\)</span> with parameters <span class="math inline">\(\beta\)</span>. Further let <span class="math inline">\(R_i\)</span> denote the indicator for missingness in <span class="math inline">\(S_i(1)\)</span>. We proceed to estimate <span class="math inline">\(\beta\)</span> by maximizing</p>
<p><span class="math display">\[
  \prod_{i = 1}^n \left\{f(Y_i | \beta, S_i(1), Z_i)\right\}^R_i \left\{\int f(Y_i | \beta, s, Z_i) \, d \hat{F}_{S(1) | W}(s | W_i)\right\}^{1 - R_i}
\]</span></p>
<p>with respect to <span class="math inline">\(\beta\)</span>.</p>
<p>This procedure is called estimated maximum likelihood (EML) and was developed in <span class="citation">Pepe and Fleming (1991)</span>. The key idea is that we are averaging the likelihood contributions for subjects missing <span class="math inline">\(S(1)\)</span> with respect to the estimated distribution of <span class="math inline">\(S(1) | W\)</span>. A BIP <span class="math inline">\(W\)</span> that is strongly associated with <span class="math inline">\(S(1)\)</span> is needed for adequate performance.</p>
<p>Closed-form inference is not available for EML estimates, thus we recommend use of the bootstrap for estimation of standard errors. It was suggested as an approach to prinicipal surrogate evaluation by <span class="citation">P. Gilbert and Hudgens (2008)</span> and <span class="citation">Y Huang and Gilbert (2011)</span>.</p>
</div>
<div id="pseudoscore" class="section level2">
<h2>Pseudoscore</h2>
<p><span class="citation">Ying Huang, Gilbert, and Wolfson (2013)</span> suggest a different estimation procedure that does have a closed form variance estimator. Pseudscore estimates were also suggested in <span class="citation">J. Wolfson (2009)</span> and implemented for several special cases in <span class="citation">Ying Huang, Gilbert, and Wolfson (2013)</span>. We have implemented here only one of the special cases: categorical <span class="math inline">\(BIP\)</span> and binary <span class="math inline">\(Y\)</span> (<span class="math inline">\(S\)</span> may be continuous or categorical). In addition to having closed form variance estimators, it has been argued that the pseudo-score estimators are more efficient than the EML estimators. The closed form variance estimates are not yet implemented.</p>
</div>
<div id="package-features" class="section level2">
<h2>Package features</h2>
<p>The <code>pseval</code> package allows users to specify the type of augmented design that suits their data, specify the form of the risk model along with the distribution of <span class="math inline">\(Y | S(1)\)</span>, and specify different integration models to estimate the distribution of <span class="math inline">\(S(1) | W\)</span>. Then the likelihood can be maximized and bootstraps run. Post-estimation summaries are available to display and analyze the treatment efficacy as a function of <span class="math inline">\(S(1)\)</span>. All of this is implemented with a flexible and familiar interface.</p>
</div>
</div>
<div id="package-information" class="section level1">
<h1>Package information</h1>
<div id="installation" class="section level2">
<h2>Installation</h2>
<p><code>pseval</code> is an R package aimed at implementing existing methods for surrogate evaluation using a flexible and common interface. It is still in active development and testing. Development will take place on <a href="https://github.com/sachsmc/pseval">the Github page</a>, and the current version of the package can be installed as shown below. First you must install the <code>devtools</code> package, if you haven’t already <code>install.packages(&quot;devtools&quot;)</code>.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">devtools::<span class="kw">install_github</span>(<span class="st">&quot;sachsmc/pseval&quot;</span>)</code></pre></div>
</div>
<div id="usage" class="section level2">
<h2>Usage</h2>
<p>Here we will walk through some basic analyses from the point of view of a new R user. Along the way we will highlight the main features of <code>pseval</code>. <code>pseval</code> supports both binary outcomes and time-to-event, thus we will also need to load the <code>survival</code> package.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">library</span>(pseval)
<span class="kw">library</span>(survival)</code></pre></div>
<div id="example-dataset" class="section level3">
<h3>Example dataset</h3>
<p>First let’s create an example dataset. The pseval package provides the function <code>generate_example_data</code> which takes a single argument: the sample size.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">set.seed</span>(<span class="dv">500</span>)
fakedata &lt;-<span class="st"> </span><span class="kw">generate_example_data</span>(<span class="dt">n =</span> <span class="dv">500</span>)
<span class="kw">head</span>(fakedata)</code></pre></div>
<pre><code>##   Z        BIP        CPV        BSM       S.obs   time.obs event.obs
## 1 1 -1.3750828         NA -1.2920364 -0.44857008 0.05371734         0
## 2 1  1.7486913         NA  1.3904835  2.51685563 0.02635337         1
## 3 1 -0.7912315         NA -0.9548101  0.16265260 0.52200085         1
## 4 0 -0.8785292         NA -0.8978026 -1.06017964 0.23835140         1
## 5 1 -0.7090188         NA -0.8677538  0.08851823 0.02961862         1
## 6 0 -1.5077543 -0.3254224 -1.6232399 -1.65234681 0.13822338         1
##   Y.obs     S.obs.cat       BIP.cat
## 1     1 (-Inf,-0.226] (-Inf,-0.688]
## 2     0   (1.24, Inf]  (0.663, Inf]
## 3     0 (-0.226,0.45] (-Inf,-0.688]
## 4     1 (-Inf,-0.226] (-Inf,-0.688]
## 5     0 (-0.226,0.45] (-Inf,-0.688]
## 6     0 (-Inf,-0.226] (-Inf,-0.688]</code></pre>
<p>The example data includes both a time-to-event outcome, a binary outcome, a surrogate, a BIP, CPV, and BSM, and a categorical version of the surrogate. The true model for the time is exponential, with parameters (intercept) = 1, S(1) = -0.5, Z = 0, S(1):Z = -1. The true model for binary is logistic, with the same parameter values.</p>
<p>In the above table S.obs.cat and BIP.cat are formed as <code>S.obs.cat &lt;- factor(S.obs,levels=c(-Inf, quantile(c(S.0, S.1), c(.25, .5, .75), na.rm = TRUE), Inf))</code> and similarly for BIP.cat. Alternatively a user could input arbitrary numeric values to represent different discrete subgroups (e.g., 0s and 1s to denote 2 subgroups).</p>
</div>
<div id="the-psdesign-object" class="section level3">
<h3>The <code>psdesign</code> object</h3>
<p>We begin by creating a <code>psdesign</code> object with the synonymous function. This is the object that combines the raw dataset with information about the study design and the structure of the data. Subsequent analysis will operate on this psdesign object. It is analogous to the <code>svydesign</code> function in the <a href="https://cran.r-project.org/package=survey">survey</a> package. The first argument is the data frame where the data are stored. All subsequent arguments describe the mappings from the variable names in the data frame to important variables in the PS analysis, using the same notation as above. An optional weights argument describes the sampling weights, if any. Our first analysis will use the binary version of the outcome, with continuous <span class="math inline">\(S.1\)</span> and the BIP labeled <span class="math inline">\(BIP\)</span>. The object has a print method, so we can inspect the result.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">binary.ps &lt;-<span class="st"> </span><span class="kw">psdesign</span>(<span class="dt">data =</span> fakedata, <span class="dt">Z =</span> Z, <span class="dt">Y =</span> Y.obs, <span class="dt">S =</span> S.obs, <span class="dt">BIP =</span> BIP)
binary.ps</code></pre></div>
<pre><code>## Augmented data frame:  500  obs. by  6  variables. 
##   Z Y     S.1   S.0 cdfweights    BIP
## 1 1 1 -0.4486    NA          1 -1.375
## 2 1 0  2.5169    NA          1  1.749
## 3 1 0  0.1627    NA          1 -0.791
## 4 0 1      NA -1.06          1 -0.879
## 5 1 0  0.0885    NA          1 -0.709
## 6 0 0      NA -1.65          1 -1.508
## 
## Empirical VE:  0.548 
## 
## Mapped variables: 
##   Z  -&gt;  Z 
##   Y  -&gt;  Y.obs 
##   S  -&gt;  S.obs 
##   BIP  -&gt;  BIP 
## 
## Integration models: 
##  None present, see ?add_integration for information on integration models.
## 
## Risk models: 
##  None present, see ?add_riskmodel for information on risk models.
##  No estimates present, see ?ps_estimate.
##  No bootstraps present, see ?ps_bootstrap.</code></pre>
<p>The printout displays a brief description of the data, including the empirical vaccine efficacy estimate, the variables used in the analysis and their corresponding variables in the original dataset. Finally the printout invites the user to see the help page for <code>add_integration</code>, in order to add an integration model to the psdesign object, the next step in the analysis.</p>
<p><code>psdesign</code> easily accomodates case-control or case-cohort sampling. Let’s modify the fake dataset to see how it works. We’re going to sample all of the cases, and 20% of the controls for measurement of <span class="math inline">\(S\)</span>.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">fakedata.cc &lt;-<span class="st"> </span>fakedata
missdex &lt;-<span class="st"> </span><span class="kw">sample</span>((<span class="dv">1</span>:<span class="kw">nrow</span>(fakedata.cc))[fakedata.cc$Y.obs ==<span class="st"> </span><span class="dv">0</span>], 
       <span class="dt">size =</span> <span class="kw">floor</span>(<span class="kw">sum</span>(fakedata.cc$Y.obs ==<span class="st"> </span><span class="dv">0</span>) *<span class="st"> </span>.<span class="dv">8</span>))
fakedata.cc[missdex, ]$S.obs &lt;-<span class="st"> </span><span class="ot">NA</span>
fakedata.cc$weights &lt;-<span class="st"> </span><span class="kw">ifelse</span>(fakedata.cc$Y.obs ==<span class="st"> </span><span class="dv">1</span>, <span class="dv">1</span>, .<span class="dv">2</span>)</code></pre></div>
<p>Now we can create the <code>psdesign</code> object, using the entire dataset (including those missing <code>S.obs</code>) and passing the weights to the <code>weights</code> field.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">binary.cc &lt;-<span class="st"> </span><span class="kw">psdesign</span>(<span class="dt">data =</span> fakedata.cc, <span class="dt">Z =</span> Z, <span class="dt">Y =</span> Y.obs, <span class="dt">S =</span> S.obs, <span class="dt">BIP =</span> BIP, <span class="dt">weights =</span> weights)
binary.cc</code></pre></div>
<pre><code>## Augmented data frame:  500  obs. by  6  variables. 
##   Z Y    S.1   S.0 cdfweights    BIP
## 1 1 1 -0.449    NA        1.0 -1.375
## 2 1 0     NA    NA        0.2  1.749
## 3 1 0     NA    NA        0.2 -0.791
## 4 0 1     NA -1.06        1.0 -0.879
## 5 1 0     NA    NA        0.2 -0.709
## 6 0 0     NA    NA        0.2 -1.508
## 
## Empirical VE:  0.548 
## 
## Mapped variables: 
##   Z  -&gt;  Z 
##   Y  -&gt;  Y.obs 
##   S  -&gt;  S.obs 
##   BIP  -&gt;  BIP 
##   weights  -&gt;  weights 
## 
## Integration models: 
##  None present, see ?add_integration for information on integration models.
## 
## Risk models: 
##  None present, see ?add_riskmodel for information on risk models.
##  No estimates present, see ?ps_estimate.
##  No bootstraps present, see ?ps_bootstrap.</code></pre>
<p>For survival outcomes, a key assumption is that the potential surrogate is measured at a fixed time <span class="math inline">\(\tau\)</span> after entry into the study. Any subjects who have a clinical outcome prior to <span class="math inline">\(\tau\)</span> will be removed from the analysis, with a warning. If <code>tau</code> is not specified in the <code>psdesign</code> object, then it is assumed to be 0.</p>
</div>
<div id="integration-models" class="section level3">
<h3>Integration models</h3>
<p>The EML procedure requires an estimate of <span class="math inline">\(F_{S(1) | W}\)</span>, this is referred to as the integration model. Let’s see the help page for <code>add_integration</code>:</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">?add_integration</code></pre></div>
<p>For this first example, let’s use the parametric integration model. We specify the mean model for <span class="math inline">\(S(1) | W\)</span> as a formula. We can add the integration model directly to the psdesign object and inspect the results. Note that in the formula, we refer to the variable names in the augmented dataset.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">binary.ps &lt;-<span class="st"> </span>binary.ps +<span class="st"> </span><span class="kw">integrate_parametric</span>(S<span class="fl">.1</span> ~<span class="st"> </span>BIP)
binary.ps</code></pre></div>
<pre><code>## Augmented data frame:  500  obs. by  6  variables. 
##   Z Y     S.1   S.0 cdfweights    BIP
## 1 1 1 -0.4486    NA          1 -1.375
## 2 1 0  2.5169    NA          1  1.749
## 3 1 0  0.1627    NA          1 -0.791
## 4 0 1      NA -1.06          1 -0.879
## 5 1 0  0.0885    NA          1 -0.709
## 6 0 0      NA -1.65          1 -1.508
## 
## Empirical VE:  0.548 
## 
## Mapped variables: 
##   Z  -&gt;  Z 
##   Y  -&gt;  Y.obs 
##   S  -&gt;  S.obs 
##   BIP  -&gt;  BIP 
## 
## Integration models: 
##   integration model for  S.1 :
##       integrate_parametric(formula = S.1 ~ BIP )
## 
## Risk models: 
##  None present, see ?add_riskmodel for information on risk models.
##  No estimates present, see ?ps_estimate.
##  No bootstraps present, see ?ps_bootstrap.</code></pre>
<p>We can add multiple integration models to a psdesign object, say we want a model for <span class="math inline">\(S(0) | W\)</span>:</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">binary.ps +<span class="st"> </span><span class="kw">integrate_parametric</span>(S<span class="fl">.0</span> ~<span class="st"> </span>BIP)</code></pre></div>
<pre><code>## Augmented data frame:  500  obs. by  6  variables. 
##   Z Y     S.1   S.0 cdfweights    BIP
## 1 1 1 -0.4486    NA          1 -1.375
## 2 1 0  2.5169    NA          1  1.749
## 3 1 0  0.1627    NA          1 -0.791
## 4 0 1      NA -1.06          1 -0.879
## 5 1 0  0.0885    NA          1 -0.709
## 6 0 0      NA -1.65          1 -1.508
## 
## Empirical VE:  0.548 
## 
## Mapped variables: 
##   Z  -&gt;  Z 
##   Y  -&gt;  Y.obs 
##   S  -&gt;  S.obs 
##   BIP  -&gt;  BIP 
## 
## Integration models: 
##   integration model for  S.1 :
##       integrate_parametric(formula = S.1 ~ BIP )
##   integration model for  S.0 :
##       integrate_parametric(formula = S.0 ~ BIP )
## 
## Risk models: 
##  None present, see ?add_riskmodel for information on risk models.
##  No estimates present, see ?ps_estimate.
##  No bootstraps present, see ?ps_bootstrap.</code></pre>
<p>In a future version of the package, we will allow for estimation of the joint risk estimands that depend on both <span class="math inline">\(S(0)\)</span> and <span class="math inline">\(S(1)\)</span>. We can also use splines or other transformations in the formula:</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">library</span>(splines)
binary.ps +<span class="st"> </span><span class="kw">integrate_parametric</span>(S<span class="fl">.1</span> ~<span class="st"> </span>BIP^<span class="dv">2</span>)</code></pre></div>
<pre><code>## Augmented data frame:  500  obs. by  6  variables. 
##   Z Y     S.1   S.0 cdfweights    BIP
## 1 1 1 -0.4486    NA          1 -1.375
## 2 1 0  2.5169    NA          1  1.749
## 3 1 0  0.1627    NA          1 -0.791
## 4 0 1      NA -1.06          1 -0.879
## 5 1 0  0.0885    NA          1 -0.709
## 6 0 0      NA -1.65          1 -1.508
## 
## Empirical VE:  0.548 
## 
## Mapped variables: 
##   Z  -&gt;  Z 
##   Y  -&gt;  Y.obs 
##   S  -&gt;  S.obs 
##   BIP  -&gt;  BIP 
## 
## Integration models: 
##   integration model for  S.1 :
##       integrate_parametric(formula = S.1 ~ BIP^2 )
## 
## Risk models: 
##  None present, see ?add_riskmodel for information on risk models.
##  No estimates present, see ?ps_estimate.
##  No bootstraps present, see ?ps_bootstrap.</code></pre>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">binary.ps +<span class="st"> </span><span class="kw">integrate_parametric</span>(S<span class="fl">.1</span> ~<span class="st"> </span><span class="kw">bs</span>(BIP, <span class="dt">df =</span> <span class="dv">3</span>))</code></pre></div>
<pre><code>## Augmented data frame:  500  obs. by  6  variables. 
##   Z Y     S.1   S.0 cdfweights    BIP
## 1 1 1 -0.4486    NA          1 -1.375
## 2 1 0  2.5169    NA          1  1.749
## 3 1 0  0.1627    NA          1 -0.791
## 4 0 1      NA -1.06          1 -0.879
## 5 1 0  0.0885    NA          1 -0.709
## 6 0 0      NA -1.65          1 -1.508
## 
## Empirical VE:  0.548 
## 
## Mapped variables: 
##   Z  -&gt;  Z 
##   Y  -&gt;  Y.obs 
##   S  -&gt;  S.obs 
##   BIP  -&gt;  BIP 
## 
## Integration models: 
##   integration model for  S.1 :
##       integrate_parametric(formula = S.1 ~ bs(BIP, df = 3) )
## 
## Risk models: 
##  None present, see ?add_riskmodel for information on risk models.
##  No estimates present, see ?ps_estimate.
##  No bootstraps present, see ?ps_bootstrap.</code></pre>
<p>These are shown as examples, we will proceed with the simple linear model for integration.</p>
<p>The next step is to define the risk model.</p>
</div>
<div id="risk-models-and-likelihoods" class="section level3">
<h3>Risk models and likelihoods</h3>
<p>Let’s see how to add a risk model:</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">?add_riskmodel</code></pre></div>
<p>Let’s add a simple binary risk model using the logit link. The argument <code>D</code> specifies the number of samples to use for the simulated annealing aka empirical integration in the EML procedure. In general, D should be set to something reasonably large, like 2 or 3 times the sample size. We use a smaller D so that this vignette builds in a reasonable amount of time.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">binary.ps &lt;-<span class="st"> </span>binary.ps +<span class="st"> </span><span class="kw">risk_binary</span>(<span class="dt">model =</span> Y ~<span class="st"> </span>S<span class="fl">.1</span> *<span class="st"> </span>Z, <span class="dt">D =</span> <span class="dv">50</span>, <span class="dt">risk =</span> risk.logit)
binary.ps</code></pre></div>
<pre><code>## Augmented data frame:  500  obs. by  6  variables. 
##   Z Y     S.1   S.0 cdfweights    BIP
## 1 1 1 -0.4486    NA          1 -1.375
## 2 1 0  2.5169    NA          1  1.749
## 3 1 0  0.1627    NA          1 -0.791
## 4 0 1      NA -1.06          1 -0.879
## 5 1 0  0.0885    NA          1 -0.709
## 6 0 0      NA -1.65          1 -1.508
## 
## Empirical VE:  0.548 
## 
## Mapped variables: 
##   Z  -&gt;  Z 
##   Y  -&gt;  Y.obs 
##   S  -&gt;  S.obs 
##   BIP  -&gt;  BIP 
## 
## Integration models: 
##   integration model for  S.1 :
##       integrate_parametric(formula = S.1 ~ BIP )
## 
## Risk models: 
##   risk_binary(model = Y ~ S.1 * Z, D = 50, risk = risk.logit )
## 
##  No estimates present, see ?ps_estimate.
##  No bootstraps present, see ?ps_bootstrap.</code></pre>
</div>
<div id="estimation-and-bootstrap" class="section level3">
<h3>Estimation and Bootstrap</h3>
<p>We estimate the parameters and bootstrap using the same type of syntax. We can add a <code>ps_estimate</code> object, which takes optional arguments <code>start</code> for starting values, and other arguments that are passed to the <code>optim</code> function. The <code>method = &quot;BFGS&quot;</code> determines the optimization method, we have found that “BFGS” works well in these types of problems.</p>
<p>The <code>ps_bootstrap</code> function takes the additional arguments <code>n.boots</code> for the number of bootstrap replicates, and <code>progress.bar</code> which is a logical that displays a progress bar in the R console if true. It is helpful to pass the estimates as starting values in the bootstrap resampling.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">binary.est &lt;-<span class="st"> </span>binary.ps +<span class="st"> </span><span class="kw">ps_estimate</span>(<span class="dt">method =</span> <span class="st">&quot;BFGS&quot;</span>)
binary.boot &lt;-<span class="st"> </span>binary.est +<span class="st"> </span><span class="kw">ps_bootstrap</span>(<span class="dt">n.boots =</span> <span class="dv">50</span>, <span class="dt">progress.bar =</span> <span class="ot">FALSE</span>, 
                            <span class="dt">start =</span> binary.est$estimates$par, <span class="dt">method =</span> <span class="st">&quot;BFGS&quot;</span>)
binary.boot</code></pre></div>
<pre><code>## Augmented data frame:  500  obs. by  6  variables. 
##   Z Y     S.1   S.0 cdfweights    BIP
## 1 1 1 -0.4486    NA          1 -1.375
## 2 1 0  2.5169    NA          1  1.749
## 3 1 0  0.1627    NA          1 -0.791
## 4 0 1      NA -1.06          1 -0.879
## 5 1 0  0.0885    NA          1 -0.709
## 6 0 0      NA -1.65          1 -1.508
## 
## Empirical VE:  0.548 
## 
## Mapped variables: 
##   Z  -&gt;  Z 
##   Y  -&gt;  Y.obs 
##   S  -&gt;  S.obs 
##   BIP  -&gt;  BIP 
## 
## Integration models: 
##   integration model for  S.1 :
##       integrate_parametric(formula = S.1 ~ BIP )
## 
## Risk models: 
##   risk_binary(model = Y ~ S.1 * Z, D = 50, risk = risk.logit )
## 
## Estimated parameters:
## (Intercept)         S.1           Z       S.1:Z 
##     -1.0274      0.0383     -0.2231     -1.3861 
##  Convergence:  TRUE 
## 
## Bootstrap replicates:
##             boot.se lower.CL.2.5% upper.CL.97.5%
## (Intercept)   0.207        -1.394         -0.698
## S.1           0.152        -0.256          0.280
## Z             0.328        -0.823          0.248
## S.1:Z         0.332        -2.199         -0.883
## 
##   Out of 50 bootstraps,  50 converged ( 100 %)
## 
##   Test for wide effect modification on 1 degree of freedom. 2-sided p value  &lt; .0001</code></pre>
</div>
<div id="do-it-all-at-once" class="section level3">
<h3>Do it all at once</h3>
<p>The next code chunk shows how the model can be defined and estimated all at once.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">binary.est &lt;-<span class="st"> </span><span class="kw">psdesign</span>(<span class="dt">data =</span> fakedata, <span class="dt">Z =</span> Z, <span class="dt">Y =</span> Y.obs, <span class="dt">S =</span> S.obs, <span class="dt">BIP =</span> BIP) +<span class="st"> </span>
<span class="st">  </span><span class="kw">integrate_parametric</span>(S<span class="fl">.1</span> ~<span class="st"> </span>BIP) +<span class="st"> </span>
<span class="st">  </span><span class="kw">risk_binary</span>(<span class="dt">model =</span> Y ~<span class="st"> </span>S<span class="fl">.1</span> *<span class="st"> </span>Z, <span class="dt">D =</span> <span class="dv">50</span>, <span class="dt">risk =</span> risk.logit) +<span class="st"> </span>
<span class="st">  </span><span class="kw">ps_estimate</span>(<span class="dt">method =</span> <span class="st">&quot;BFGS&quot;</span>)</code></pre></div>
</div>
<div id="plots-and-summaries" class="section level3">
<h3>Plots and summaries</h3>
<p>We provide summary and plotting methods for the psdesign object. If bootstrap replicates are present, the summary method does a test for wide effect modification. Under the parametric risk models implemented in this package, the test for wide effect modification is equivalent to a test that the <span class="math inline">\(S(1):Z\)</span> coefficient is different from 0. This is implemented using a Wald test using the bootstrap estimate of the variance.</p>
<p>Another way to assess wide effect modification is to compute the standardized total gain (STG) <span class="citation">(Erin E. Gabriel, Sachs, and Gilbert 2015)</span>. This is implemented in the <code>calc_STG</code> function. The standardized total gain can be interpreted as the area sandwiched between the risk difference curve and the horizontal line at the marginal risk difference. It is a measure of the spread of the distribution of the risk difference, and is a less parametric way to test for wide effect modification. The <code>calc_STG</code> function computes the STG at the estimated parameters, at the bootstrap samples, if present and provides a 95% percentile CI. It should be noted that as pointed out in <span class="citation">Erin E. Gabriel and Gilbert (2014)</span>, this CI will almost never include 0, as STG is always positive and therefore is not of great use for the evaluation of surrogates having any value. The CI instead can be used to compare surrogates. <em>In a future update we will include a p-value and bootstrap for the comparison of STGs between surrogates.</em> The function prints the results and invisibly returns a list containing the observed STG and the bootstrapped STGs. If the outcome is time to event the STG is time-dependent, and a time point for evaluation is needed, if one is not provided then the restricted mean survival is estimated from the data and used.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">calc_STG</span>(binary.boot)</code></pre></div>
<pre><code>## $obsSTG
## [1] 0.414973
## 
## $bootstraps
##    STG.boot.se STG.lower.CL.2.5 STG.upper.CL.97.5
## V1   0.1484837        0.1587935          0.731445</code></pre>
<p>The summary method also computes the marginal vaccine efficacy marginalized over <span class="math inline">\(S(1)\)</span> and compares it to the average vaccine efficacy conditional on <span class="math inline">\(S(1)\)</span>. This is an assessment of model fit. A warning will be given if the two estimates are dramatically different. These estimates are presented in the summary along with the empirical marginal vaccine efficacy.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">smary &lt;-<span class="st"> </span><span class="kw">summary</span>(binary.boot)</code></pre></div>
<pre><code>## Augmented data frame:  500  obs. by  6  variables. 
##   Z Y     S.1   S.0 cdfweights    BIP
## 1 1 1 -0.4486    NA          1 -1.375
## 2 1 0  2.5169    NA          1  1.749
## 3 1 0  0.1627    NA          1 -0.791
## 4 0 1      NA -1.06          1 -0.879
## 5 1 0  0.0885    NA          1 -0.709
## 6 0 0      NA -1.65          1 -1.508
## 
## Empirical VE:  0.548 
## 
## Mapped variables: 
##   Z  -&gt;  Z 
##   Y  -&gt;  Y.obs 
##   S  -&gt;  S.obs 
##   BIP  -&gt;  BIP 
## 
## Integration models: 
##   integration model for  S.1 :
##       integrate_parametric(formula = S.1 ~ BIP )
## 
## Risk models: 
##   risk_binary(model = Y ~ S.1 * Z, D = 50, risk = risk.logit )
## 
## Estimated parameters:
## (Intercept)         S.1           Z       S.1:Z 
##     -1.0274      0.0383     -0.2231     -1.3861 
##  Convergence:  TRUE 
## 
## Bootstrap replicates:
##             boot.se lower.CL.2.5% upper.CL.97.5%
## (Intercept)   0.207        -1.394         -0.698
## S.1           0.152        -0.256          0.280
## Z             0.328        -0.823          0.248
## S.1:Z         0.332        -2.199         -0.883
## 
##   Out of 50 bootstraps,  50 converged ( 100 %)
## 
##   Test for wide effect modification on 1 degree of freedom. 2-sided p value  &lt; .0001 
## 
## Vaccine Efficacy: 
## empirical  marginal     model 
##     0.548     0.548     0.567 
##  Model-based average VE is 3.3 % different from the empirical and 3.3 % different from the marginal.</code></pre>
<p>The <code>calc_risk</code> function computes the risk in each treatment arm, and contrasts of the risks. By default it computes the vaccine efficacy, but there are other contrast functions available. The contrast function is a function that takes 2 inputs, the <span class="math inline">\(risk_0\)</span> and <span class="math inline">\(risk_1\)</span>, and returns some one dimensional function of those two inputs. It must be vectorized. Some built-in functions are “VE” for vaccine efficacy <span class="math inline">\(= 1 - risk_1(s)/risk_0(s)\)</span>, “RR” for relative risk <span class="math inline">\(= risk_1(s)/risk_0(s)\)</span>, “logRR” for log of the relative risk, and “RD” for the risk difference <span class="math inline">\(= risk_1(s) -risk_0(s)\)</span>. You can pass the name of the function, or the function itself to <code>calc_risk</code>. See <code>?calc_risk</code> for more information about contrast functions.</p>
<p>Other arguments of the <code>calc_risk</code> function include <code>t</code>, the time at which to calculate the risk for time-to-event outcomes, <code>n.samps</code> which is the number of samples over the range of S.1 at which the risk will be calculated, and <code>CI.type</code>, which can be <code>&quot;pointwise&quot;</code> for pointwise confidence intervals or <code>&quot;band&quot;</code> for a simultaneous confidence band. <code>sig.level</code> is the significance level for the bootstrap confidence intervals.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">head</span>(<span class="kw">calc_risk</span>(binary.boot, <span class="dt">contrast =</span> <span class="st">&quot;VE&quot;</span>, <span class="dt">n.samps =</span> <span class="dv">20</span>))</code></pre></div>
<pre><code>##           S.1           Y        R0        R1 Y.boot.se Y.upper.CL.0.95
## V1 -1.5751880 -1.79819929 0.2520468 0.7052772 1.0287502      -0.2656671
## V2 -1.5526586 -1.77121329 0.2522095 0.6989264 1.0129742      -0.2582064
## V3 -1.4825804 -1.68556673 0.2527161 0.6786859 0.9643074      -0.2342474
## V4 -0.7463092 -0.70161884 0.2580788 0.4391517 0.4974757       0.1570358
## V5 -0.4058894 -0.27043421 0.2605832 0.3310538 0.3278760       0.4230819
## V6 -0.2398308 -0.08278968 0.2618106 0.2834858 0.2636571       0.5289496
##    Y.lower.CL.0.95 R0.boot.se R0.upper.CL.0.95 R0.lower.CL.0.95 R1.boot.se
## V1      -3.9308621 0.08064895        0.4023271        0.1217936 0.10738861
## V2      -3.8737738 0.08004409        0.4012217        0.1226830 0.10758649
## V3      -3.6935440 0.07816451        0.3977899        0.1254850 0.10793841
## V4      -1.6792966 0.05873369        0.3623962        0.1583430 0.08263874
## V5      -0.8380837 0.05013772        0.3464977        0.1757562 0.05962479
## V6      -0.5457982 0.04611346        0.3388625        0.1847825 0.05003531
##    R1.upper.CL.0.95 R1.lower.CL.0.95
## V1        0.8918312        0.5090898
## V2        0.8868528        0.5030959
## V3        0.8700738        0.4844536
## V4        0.5912970        0.2921108
## V5        0.4366414        0.1923320
## V6        0.3711245        0.1540595</code></pre>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">head</span>(<span class="kw">calc_risk</span>(binary.boot, <span class="dt">contrast =</span> function(R0, R1) <span class="dv">1</span> -<span class="st"> </span>R1/R0, <span class="dt">n.samps =</span> <span class="dv">20</span>))</code></pre></div>
<pre><code>##           S.1          Y        R0        R1 Y.boot.se Y.upper.CL.0.95
## V1 -1.7480531 -1.9955950 0.2508007 0.7512973 1.1518466      -0.3188161
## V2 -0.7596160 -0.7194033 0.2579812 0.4435738 0.5049431       0.1454348
## V3 -0.5869737 -0.4933064 0.2592491 0.3871383 0.4124870       0.2893471
## V4 -0.4512623 -0.3246331 0.2602485 0.3447338 0.3477215       0.3913401
## V5 -0.2118829 -0.0529730 0.2620175 0.2758974 0.2541778       0.5451843
## V6  0.1718713  0.3011417 0.2648696 0.1851063 0.1595495       0.7251876
##    Y.lower.CL.0.95 R0.boot.se R0.upper.CL.0.95 R0.lower.CL.0.95 R1.boot.se
## V1    -4.354389469 0.08529788        0.4025861        0.1151532 0.10466663
## V2    -1.714822363 0.05907675        0.3544168        0.1576917 0.08351635
## V3    -1.267403356 0.05466294        0.3462684        0.1663126 0.07174096
## V4    -0.941159172 0.05125972        0.3401241        0.1733511 0.06254421
## V5    -0.504876107 0.04545069        0.3365388        0.1863364 0.04861714
## V6    -0.009987903 0.03694636        0.3308303        0.1942952 0.03462412
##    R1.upper.CL.0.95 R1.lower.CL.0.95
## V1        0.9239870       0.55339183
## V2        0.5971795       0.29657438
## V3        0.5192905       0.24186548
## V4        0.4572009       0.20397207
## V5        0.3618222       0.14826859
## V6        0.2464485       0.08564535</code></pre>
<p>It is easy to plot the risk estimates.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">plot</span>(binary.boot, <span class="dt">contrast =</span> <span class="st">&quot;VE&quot;</span>, <span class="dt">lwd =</span> <span class="dv">2</span>)
<span class="kw">abline</span>(<span class="dt">h =</span> smary$VE.estimates[<span class="dv">2</span>], <span class="dt">lty =</span> <span class="dv">2</span>)

expit &lt;-<span class="st"> </span>function(x) <span class="kw">exp</span>(x)/(<span class="dv">1</span> +<span class="st"> </span><span class="kw">exp</span>(x))
trueVE &lt;-<span class="st"> </span>function(s){
  
  r0 &lt;-<span class="st"> </span><span class="kw">expit</span>(-<span class="dv">1</span> -<span class="st"> </span><span class="dv">0</span> *<span class="st"> </span>s)
  r1 &lt;-<span class="st"> </span><span class="kw">expit</span>(-<span class="dv">1</span> -<span class="st"> </span>.<span class="dv">75</span> *<span class="st"> </span>s)
  <span class="dv">1</span> -<span class="st"> </span>r1/r0
  
}

<span class="kw">rug</span>(binary.boot$augdata$S<span class="fl">.1</span>)
<span class="kw">curve</span>(<span class="kw">trueVE</span>(x), <span class="dt">add =</span> <span class="ot">TRUE</span>, <span class="dt">col =</span> <span class="st">&quot;red&quot;</span>)
<span class="kw">legend</span>(<span class="st">&quot;bottomright&quot;</span>, <span class="dt">legend =</span> <span class="kw">c</span>(<span class="st">&quot;estimated VE&quot;</span>, <span class="st">&quot;marginal VE&quot;</span>, <span class="st">&quot;true VE&quot;</span>), 
       <span class="dt">col =</span> <span class="kw">c</span>(<span class="st">&quot;black&quot;</span>, <span class="st">&quot;black&quot;</span>, <span class="st">&quot;red&quot;</span>), <span class="dt">lty =</span> <span class="kw">c</span>(<span class="dv">1</span>, <span class="dv">3</span>, <span class="dv">1</span>), <span class="dt">lwd =</span> <span class="kw">c</span>(<span class="dv">2</span>, <span class="dv">1</span>, <span class="dv">1</span>))</code></pre></div>
<p><img src="data:image/png;base64,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" alt /><!-- --></p>
<p>By default, plots of psdesign objects with bootstrap samples will display simultaneous confidence bands for the curve. These bands <span class="math inline">\(L\alpha\)</span> satisfy</p>
<p><span class="math display">\[
P\left\{\sup_{s \in B} | \hat{VE}(s) - VE(s) | \leq L_\alpha \right\} \leq 1 - \alpha,
\]</span></p>
<p>for confidence level <span class="math inline">\(\alpha\)</span>. The alternative is to use pointwise confidence intervals, with the option <code>CI.type = &quot;pointwise&quot;</code>. These intervals satisfy</p>
<p><span class="math display">\[
P\left\{\hat{L}_\alpha \leq VE(s) \leq \hat{U}_\alpha\right\} \leq 1 - \alpha, \mbox{ for all } s. 
\]</span></p>
<p>Different summary measures are available for plotting. The options are “VE” for vaccine efficacy = <span class="math inline">\(1 - risk_1(s)/risk_0(s)\)</span>, “RR” for relative risk = <span class="math inline">\(risk_1(s)/risk_0(s)\)</span>, “logRR” for log of the relative risk, “risk” for the risk in each treatment arm, and “RD” for the risk difference = <span class="math inline">\(risk_1(s) - risk_0(s)\)</span>. We can also tranform using the <code>log</code> option of <code>plot</code>.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">plot</span>(binary.boot, <span class="dt">contrast =</span> <span class="st">&quot;logRR&quot;</span>, <span class="dt">lwd =</span> <span class="dv">2</span>)</code></pre></div>
<p><img src="data:image/png;base64,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" alt /><!-- --></p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">plot</span>(binary.boot, <span class="dt">contrast =</span> <span class="st">&quot;RR&quot;</span>, <span class="dt">log =</span> <span class="st">&quot;y&quot;</span>, <span class="dt">lwd =</span> <span class="dv">2</span>)</code></pre></div>
<p><img src="data:image/png;base64,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" alt /><!-- --></p>
<p>The <code>calc_risk</code> function is the workhorse that creates the plots. You can call this function directly to obtain estimates, standard errors, and confidence intervals for the estimated risk in each treatment arm and transformations of the risk like VE. The parameter <code>n.samps</code> determines the number of points at which to calculate the VE. The points are evenly spaced over the range of S.1. Use this function to compute other summaries, make plots using <code>ggplot2</code> or <code>lattice</code> and more.</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">ve.est &lt;-<span class="st"> </span><span class="kw">calc_risk</span>(binary.boot, <span class="dt">CI.type =</span> <span class="st">&quot;pointwise&quot;</span>, <span class="dt">n.samps =</span> <span class="dv">200</span>)
<span class="kw">head</span>(ve.est)</code></pre></div>
<pre><code>##          S.1         Y        R0        R1 Y.boot.se Y.lower.CL.2.5
## V1 -1.427824 -1.616958 0.2531124 0.6623845 0.9267150      -4.209167
## V2 -1.317857 -1.475235 0.2539094 0.6284855 0.8524065      -3.873989
## V3 -1.224981 -1.352148 0.2545839 0.5988191 0.7909359      -3.548021
## V4 -1.186491 -1.300426 0.2548638 0.5862952 0.7658246      -3.397932
## V5 -1.181613 -1.293846 0.2548993 0.5846996 0.7626577      -3.379011
## V6 -1.172832 -1.281988 0.2549632 0.5818228 0.7569660      -3.345012
##    Y.upper.CL.97.5 R0.boot.se R0.lower.CL.2.5 R0.upper.CL.97.5 R1.boot.se
## V1      -0.4309737 0.07669808       0.1506936        0.4022073  0.1079175
## V2      -0.3464274 0.07376000       0.1543645        0.3957504  0.1070197
## V3      -0.2746093 0.07128710       0.1575216        0.3903252  0.1053042
## V4      -0.2448669 0.07026496       0.1588453        0.3880848  0.1043243
## V5      -0.2411013 0.07013554       0.1590137        0.3878012  0.1041887
## V6      -0.2343257 0.06990263       0.1593173        0.3872908  0.1039381
##    R1.lower.CL.2.5 R1.upper.CL.97.5
## V1       0.4688431        0.8508278
## V2       0.4398617        0.8183488
## V3       0.4156920        0.7867895
## V4       0.4057864        0.7725791
## V5       0.4045363        0.7707307
## V6       0.4022890        0.7673767</code></pre>
</div>
</div>
<div id="note-about-d" class="section level2">
<h2>Note about D</h2>
<p>In the examples above, <code>D</code> was set to a small number so that the vignette can be built in a timely manner. This parameter is the number of samples to use for the empirical integration in the estimated maximum likelihood. In real applications, we recommend using a much larger <code>D</code>, a least the sample size, and possibly some multple of the sample size. Note that it will take much longer to run with a higher <code>D</code>, but the results will be more accurate.</p>
</div>
<div id="additional-examples" class="section level2">
<h2>Additional examples</h2>
<div id="plot-both-types-of-ci" class="section level3">
<h3>Plot both types of CI</h3>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">plot</span>(binary.boot, <span class="dt">contrast =</span> <span class="st">&quot;VE&quot;</span>, <span class="dt">lwd =</span> <span class="dv">2</span>, <span class="dt">CI.type =</span> <span class="st">&quot;band&quot;</span>)
sbs &lt;-<span class="st"> </span><span class="kw">calc_risk</span>(binary.boot, <span class="dt">CI.type =</span> <span class="st">&quot;pointwise&quot;</span>, <span class="dt">n.samps =</span> <span class="dv">200</span>)
<span class="kw">lines</span>(Y.lower.CL<span class="fl">.2.5</span> ~<span class="st"> </span>S<span class="fl">.1</span>, <span class="dt">data =</span> sbs, <span class="dt">lty =</span> <span class="dv">3</span>, <span class="dt">lwd =</span> <span class="dv">2</span>)
<span class="kw">lines</span>(Y.upper.CL<span class="fl">.97.5</span> ~<span class="st"> </span>S<span class="fl">.1</span>, <span class="dt">data =</span> sbs, <span class="dt">lty =</span> <span class="dv">3</span>, <span class="dt">lwd =</span> <span class="dv">2</span>)
<span class="kw">legend</span>(<span class="st">&quot;bottomright&quot;</span>, <span class="dt">lwd =</span> <span class="dv">2</span>, <span class="dt">lty =</span> <span class="dv">1</span>:<span class="dv">3</span>, <span class="dt">legend =</span> <span class="kw">c</span>(<span class="st">&quot;estimate&quot;</span>, <span class="st">&quot;simultaneous CI&quot;</span>, <span class="st">&quot;pointwise CI&quot;</span>))</code></pre></div>
<p><img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAqAAAAHgCAMAAABNUi8GAAAAclBMVEUAAAAAADoAAGYAOjoAOmYAOpAAZrY6AAA6ADo6AGY6OpA6kLY6kNtmAABmADpmOgBmZgBmZmZmkJBmtrZmtv+QOgCQZgCQtpCQ2/+2ZgC2kDq225C2///bkDrb/7bb////tmb/trb/25D//7b//9v///8jan4dAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAVh0lEQVR4nO2diXYbtxVA6bSWnVZO28RqxDaMWUn8/18sZ+UMOQuW92YegHvPiWWFQwwIXj8sg+VwATDMYe8MACyBoGAaBAXTICiYBkHBNAgKpkFQMA2CgmkQFEyDoGAaBAXTICiYBkHBNAgKpkFQMA2CgmkQFEyDoGAaBAXTICiYBkHBNAgKpkFQMA2CgmkQFEyDoGAaBAXTICiYBkHBNAgKpkFQMA2CgmkQFEyDoGAaBAXTICiYBkHBNAgKpkFQMA2CgmkQFEyDoGAaBAXTICiYBkHBNAgKpkFQMA2CgmkQFEyDoGAaBAXTICiYBkHBNAgKpkFQMA2CgmkQFEyDoGAaBAXTICiYBkHBNAgKpkFQMA2CgmkQFEyDoGAaBAXTICiYBkHBNAgKpkFQMA2CgmkQFEyDoGAaBAXTICiYBkHBNMKCHgCc0BH046VJ/ac/RJKDYtER9HR4bv5y7v4SlRyUi4qgHy+9lqfPP6KTg4JREfT92/fur+eZSh5BwQkiKJhGqw3ahlDaoBCHUi/+/VvTi5+JnwgKjigJunVykCsICqbRFvREL94A909lln6v/pT83ff+91l3/oyuFy6n4v0ECyZx/8avf4wKfeX3g//vckx9UOcSCSvIjZLLnruv0N247j1rPxfvuhVTWXAuIdcLd0kuQ0bf2fArbLRr/rt4Grd6OxGpJEFQY8wYeel/RorY3WZH++4SX74Zgpph9DUthMjYGwirOP7nM9XNWBFyB0G7YfoKevGOPERMkQCmLuR9ko+3iLulTgT9eJmdCBqSXLbcfXHjOjw6XTkpb5kb9eLvbja+UAilKv7j5UkyuUzpv1ipkKkQKbugLhYSfbMhfmHD+fB98XUEFWxcPooZlVaf5H3SkbkMy474hbsklxDDb/r27CUqORGDZqvwy15uNjcXv3CX5FKh++YFWpvRZvZG3vezd4yXjyDolgzqzchUYtwc1N2XxwdRxkDQTREcygy++2EQM+NyswUIqs1d5RmZTphW45h5lynbIKgyQh2YwERuMdNwLb4IgupyGHRFQhOIaGyOY2ZgFnYFQVUY2CDSUw94Z7IxcwyCKjDyIvQZdJhfg3GC5N2sQVBxBNQIsDOprrkHCCrNsNkX+n4fze77QSH3NAyCSvHoRni/xity5iflEAQVQSR4+ck5mGWUWWGOQFAJttXz7nlQ5H2Ng6AC3FsS1Pd2fVPb2vS7QbogaBTTH8PPH/deUSG1+ggEDUfEE8/YWUKtPgJBQ5Frd7pcFz8RKlEQNJBJswLqdvcrky+yIBBUEq/xdZeLD49L1goDQXfBeUSpm/ReLAjqh0QocwmIXX8o9l7Jg6A+zKvl8wTIQbxu6CnNYpIEQT1YMMaruyN4XfYgqAcyw0prV8jcKhcQdDtcgiJx8w4E3Yj1JiXdoilUBH3/Vh3fdT7kctrxojVuSq3rSa9oEj1B60MQB6d2hie3MyvauA23u/XbvfJVBmqCtmomf1an0BN3kbyUiJqgb19qQVM/7TheLueOO0xBBF0muvnp1Pb0zFRJKAlalfrTpesuRSZnFbdRo2XDsXMFrWGmq6OfXudP485C0FVcoudWeUkVxkFniB9aIjxKgKCTLLvlOAt+4SrcdUVb0DRPO1bvuyOoKxtH0H4amemvR3vo03wBGIIq/pGlSXWuCcxe2O6hFJKvIkFQD9ynci69ylQ6H5QE/XhpKvI8Jot4QXwURUfQUzf+OTsQmtZ36OHccu0OvqgI+vHSa5nUo87oBR2rY0v+eSodpUed/SS7lCaLbDC2FJd+iRBBO0TGPlXTLxKtNmgbQpNpg84NTbpbtTy2xNBnIEq9+GY+0+EwEz/NCTqrj1jrEz3DYBy0RuLRkUhG4A4EncHLOAKkGgg6g49yzFvSA0HjWZ0Ysl1W8qN0QYX2qlt6NfYGZVO4oBP+eCrF2LwuZQs65Y+fU6urjnyzBGNKFlSgebhcu0cmDpeiBZ3w0zNXqzM/IZqiBX34H365ooG5AQUL+oCkn7grBIKGsjY3ZMu8ZAyCBsLTo21A0DDiN3YAJ0oU9F4ff58ENh4BNwoU9MGfEEHDXwUvyhNUddsQ3JSmOEFVnx5RuYtTmqC62y7hpziFCTqWK8Qnhue3pTBBxwT4RPd9Y4oW1B8eH20NgvrA46PNKVPQMJdWd7YJzQ7Mg6C6b4JIlAQ1tz+ozOI4iZyAFzqCmtsfVEAuRj93QUVQc7vb3fwMlYnu+06oCGptf9CBQIEqrSyOQ1A1SoigqvW70A1gBq02qKX9QfEzYZR68fb2B42xiM2X9qOYcdBwjeYNrF9AT1WKETQcpn/uibagaR4mO4AafF82jqCHHpHkVu8WHeXwc2dyruIP8YKi597kK6hI7Ft+vom9+uQ6WUSmGbH2/AhB1cl1soiIPOyevD/5PurU3Z32QgW/DflOFokWdNVPBN2ArCKo6PjVWlL4uQkZTRaRHWBl93kb5DNZRHZInf0ZjJDPOGj0pORxYjhog3wEvSXNArmMyFJQ7SSwdztSF1Ql1jHAZIekBVWaGMUAkyESFlRr2t7qA04E3ZC0BX34P/GpOqyQw88NSVjQxzRF1MFPUyQoqO4JBjRAbZGcoMohjABpjMQE1e6i4Kc1khJUvQeNn+ZITdC5F2Lysp6+7G3Ag6QEnU9Natw/6nVQIAFBN/Ni7T74uQPWBd1ulwcHPxF0e0wLuuEmJFTwRjEv6OoVErlxSQk/d8G0oA7JSGlD/DSKNUG3rNTHt428AHQwJeimW9/d3XnzW4IT5gSVvY0jxEezmBLUKwHBDOGnXVIVVHgRvFxaIIuKoO/fqv1EzprbL+JnIegJWu/KNNhGLDw5ZRgBtYyaoK2aFk6aW4YRJtOoCfr2pRbUxFmdS6zrh597klwEFY5n+GkcJUGrEc2nS9ddikxu/EZRYVz8RNA98RTUYe/kS3vh4dPr/PagRqp4/DRPiKDNBsrLgordV5V1+/BzZ4oWFPvsoy2o3Fmd8pUt1XcCpBNBNQSNvwKUSUdQcRzsQ9Dd2VjQw35TPieysn7JFhmBJZQE3f2sznUc/NwiG7CMt6C3GLggqOxZnSqBjBHQNFB5kiR70twO2yg3V8jfFbwJf5K0gOxZnQTQkgmo4p9WrzVx2vEidJBSwbuKr7o/n15XLt7lrE53HEYR8NMIIW3QKozOTQIZXFKx4VmdHjiNgGKoCQI7SefFTrzkfRVwcg9BbRDei18fqB80RcPvK49TcMRPI4RH0Nnau8esoPvdG3xRaoPW2BSU1mVS6PTiu0sNCoqfaaEyDtpiUVAXP1HYECpPkiTvK4zbCBOKmkHlWfz2yTnf1qkDj6B2KEtQxwoeP+1QlKCMgKZHSYLiZ4KUJajURbAZBQmKeilSjqCuXXM8NkVJgjpehqCWKEZQV+/w0xalCEpgTJRyBN34hiBDIYLiZ6qUIahbBY/FBilCUMcGKIIapBBBHS9DUXOUIKj7CBOCmqMAQd0fIeGnPYoQVPY62JL8BcXPpFES1M4Gts71NoKaREdQ2Q1so8C7tFER1ND2ix5+orJFVASV3cA2Bp+OOYJaJO8Iip/Jo9UGNbGBLQOb6aPUi7exgS1+pk/O46D4mQEZC0oFnwPagsqdduyNu5+YbJd8I6hXBx5FrZKtoH4jTAhqlY0F3e60Y587IKhdco2gfn7q5QMiQVAENY3Ss/jVQ7uVnfByDkENoxNBP17WTvnSdcKrTYmfllGbsLxyFoi2oFoXw8ZotUHPh+XjQFSl8FQOQw2TYyfJd9AIQQ2ToaD4mROagu500hzC5UR+guJnVmQnKE8t8yI3QfEzMzITFD9zI7NevH8HHqNtk5egvrYhqHmyEtS7gmciqHlyEtTfNvQ0T0aC4meOZCWo/jtga/IRNMA2BLVPNoIGdHfwMwFyETSoO46h9slH0K3eBJuSiaBhqiGoffIQlPH2bMlFUNHkwA5ZCEoAzZdMBJVMDSyRg6D04DMmA0HDKniaBWmQhaBBb0LQJEhf0NAhUARNAhVB379Vi5HOmxwmGyhauXoeEsP5c3mUQS1ofcbc4FDE8OQWwU9PEvvkaoK2amofhRhoGoKmgpqgb19qQZUPk/WoAu7eJ3P/BEnsk6cdQfHTn8Q+upKgVev26dJ1lyKTmydctHIVTeyDaw0zXR399Dp/2LFMMUVYhqCJkPI4aGgFfynZTwTdLLkIP0smsULTFlTvMFn8DCOxUks2gob7WbjYiX36hAXd/p1ZkNin31hQ/0esswnFvLVkRxP76IlG0BjDETQl0hQUP8OR/Ozn7/PTgepX41F8ktSg0ouPMaxoOy+igi7IufqqKzoRVPkw2cgAWjYIWqF7mCwBNIKYz3+6hobq4fXbl+tfvld/fv7zquHbl9+udeZz9Xvl5LF6sb7m84/+LerZ9fxcmofJFu9YFPeF5zGd/fTp9epdO5Xy+g1XMfK9FvT6wqlqzVXPZY5PzZV1BO3eIpbd+AvVk+MRUhR3heex3qJdyfPTH90k35ugz5fuj+/vv7zWP9tX27dIZVfgQu3kov0s3O/wT3++RsPGwW+NcTdBv18Gf9TL0ZpX+rfoZzfgc6kc5LXrGH8ORAjahtXv12/20Cn4KOi11fnTf9sIenuLenbtCBr6TrkUkiY2gnYcP71OCtr/cougm2TXiKCF2yVAeAGOx42uv00KWjc4z4P4ulF2bQgaWcGjd1RnouqSV5GzjovnKoI+T0fQ92+H53bxefsW/eyaEDS2AYqg8eOgTYA8HGrzunHQuzbop9fKyWM3DhrRiU+rF08HXoDEiiAlQfFTgsTKIC1BY296QFIEVUtOZgAUQffOgB/pCCozQl+8nwiqlJzAE3jkrEisEFIRFD+lSKwUEhGUGUxiJFaQyQgqe/uCiS/J2eeX9dP3mGeb9SSUaj/E2zP8NATFTzkUi7J9PB9Ms9dc9RAqMUHFKnhEtyxoO2304+Xzj7QElWuAIuj8ko+53wc0S5Ha+SGDZUi1lbWdvzYLkZpVSdf/VV1UWdevTDo3f+ne0SVZ0212/L8/0oqggh0kBJ1f8jHz+4DhUqTRMqSboE0Eva1Kqi5q/6uXhDTT8J56Qbskq+SHCy1TEpQOvCwRE5YHS5HGy5DGgg5WJXWvtyuTmvlt52aqc/WO4Wql4W7cCQkq5CeWd8RMWL4tRRrNsLuPoJfBqqRaw25lUtPKHL3jZmiagkrFTwTtiCiIwVKkRUGHq5JqQbuVSY2g3WXVH22STeopVvH036WJLIh2KdKSoKNVSbcIeun66YN3dEnWP7tO0rVNmoyg+ClOZEncS9i3MRvt6rH64aqk0djToA36fFuN3L2c4DCT7AAollZEdJL6pUh3glZKXevqRtDny2BVUhsn+5VJXS++e0eXZHuDagTq4yWdgXrhAVAErYgohHYp0uNS+Go7w9+aSFktROpWJd0q8n5lUjsO2r2jX93UUG+LuMmjzrrtu7RcyiU5/NQgsVLQEfTUbWg2e5KXQ3IM0KuQWFGoCDpYbxx+Vid+6pBYWagIOpgxEHzaMQ+QlEisWM1GUPxUIrFy1WqDtiE0uA2Kn1okVrBKvfjuGIWZ+LmanEIFj/INiRWDzXFQjQYogjZIFsNoevJ4scfSzOWJlR2zmBQUPxXRKgf3ufRTKztm0RY05LRjOvCa7C7o5CP3WQxGUGk/0X3E45KP5Z833r7+/uVx5Ua7rqNau/HXfzy18+OP9baMtwUdw8NoJld2OGc3/sLo5KSFQtARj0s+Fn8OuOr2vfFvuHKjW9dRTwqpNwSt5oI89w/sq2uHh9FMT/t0za7AhcupLCx56S8RuZNigmkTXhqNYqdqHtJg5cZgrl0t3PFfn3+8fX3t591dBufX3H5p2E/QUzdP2rsNKt4Axc8xMYJWX+lVqtG84+Gkz+rHL7//XB2k1PzafPujw2hMCNos6atCua+g8h0kZjKNiRD0a6VTL+jgFIV+VvLx+e1vf/7yemzXbbYLOkaH0Vio4psqoOqm+Qqq5CeC3hATdCKCXuv//zxdjn9/GZzv0R260DO5siM+uyGTRY6ff/gJqvYACUF7Ytugx4c26EDQt5//+Xw5/eXr603Qh+1GDAwz9ZNFjk++gnrcxQ3UvCNG0HbRxl0vvhO0HneqL7nGyP4Yr3O7ccPtMJqplR3x2fVrg/bdt7k59ZPJ4ecGxAj6a3vg9ngctF3XUZ86c7x+33Wkrf93v6BjfBjNxMqO+Oz69uK7tc47Cwr3xPbiN8bgQD2ogqA9KofJQiQI2mNGUJoOAxIrCwQtjcTKogRB8XNIYoWRtaCYOUFiZZJ1Lx5BJ0isTBC0NBIrEwQtjcTKJGdB8XOKxAolY0Fvixf075UQiZXGboICOLGToIqJknCRCSMoCZtOGEFJ2HTCCErCphNGUBI2nTCCkrDphBGUhE0njKAkbDphBCVh0wkn9oQMSgNBwTQICqZBUDANgoJpEBRMg6BgGgQF0yAomAZBwTQICqZBUDANgoJpNAStj9GZ32Asirefp/cej+Hc7riugEZ2NQv4pFcU1TkiAe9SELQ+6KE62lGB7pAzSc5u51KEoJFdzQKuTslQKormkBB/FARttpSeO6gmivNh7niRcJrdJI8a/540sntRLOD6yJnhkXGiaZsRtEHjH+L58HwW/1r0/j2pZPeWulKkUxL09PnftgQ96nw1CoI2JwGmkt0epQJuTucS51rKZtqgNWelXpL8N95EIqV4pCeoUgGfdXpfVTvKlKBnnT4SgvYJaxVwc1iwNNVJs5YE1YqfVPFdumoFrPJvtS5jC4KemvG5k3jxnbqBv5Q6SRc1QeULeIDCwV6nds/FgIQ1IugpJCOOyH/jisNMWoJqFXCjplbUtxBBa5rzx5VQKD3FgXqdL1uvgCuHlk4Zik7cHwVB23ieTq9D8fmeiqCKBXwMq4fd0rYiKIAcCAqmQVAwDYKCaRAUTIOgYBoEBdMgKJgGQcE0CAqmQVAwDYKCaRAUTIOgYBoEBdMgKJgGQcE0CAqmQVAwDYKCaRAUTIOgYBoEBdMgKJgGQcE0CAqmQVAwDYJq8f7tMD5DQedImtxBUCXO9SZcx9sOXzpH0mQPgirRbDh6OzJD6Uia7EFQHe4Pc9E9kiZjEFSJx1MOEDQEBNXi7ctdpY6gISCoIh8vw22QETQEBNVlcB4cgoaAoDp0Z7kMTmdA0BAQVIeuF38mgsaBoEo0x6MPT4RD0BAQVIv6UWdVwU8EU3AGQcE0CAqmQVAwDYKCaRAUTIOgYBoEBdMgKJgGQcE0CAqmQVAwDYKCaRAUTIOgYBoEBdMgKJgGQcE0CAqmQVAwDYKCaRAUTIOgYBoEBdMgKJjm/+wWRX1Qwhe+AAAAAElFTkSuQmCC" alt /><!-- --></p>
</div>
<div id="plot-with-ggplot2" class="section level3">
<h3>Plot with ggplot2</h3>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">library</span>(ggplot2)
VE.est &lt;-<span class="st"> </span><span class="kw">calc_risk</span>(binary.boot, <span class="dt">n.samps =</span> <span class="dv">200</span>)
<span class="kw">ggplot</span>(VE.est, 
       <span class="kw">aes</span>(<span class="dt">x =</span> S<span class="fl">.1</span>, <span class="dt">y =</span> Y, <span class="dt">ymin =</span> Y.lower.CL<span class="fl">.0.95</span>, <span class="dt">ymax =</span> Y.upper.CL<span class="fl">.0.95</span>)) +<span class="st"> </span>
<span class="st">  </span><span class="kw">geom_line</span>() +<span class="st"> </span><span class="kw">geom_ribbon</span>(<span class="dt">alpha =</span> .<span class="dv">2</span>) +<span class="st"> </span><span class="kw">ylab</span>(<span class="kw">attr</span>(VE.est, <span class="st">&quot;Y.function&quot;</span>))</code></pre></div>
<p><img src="data:image/png;base64,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" alt /><!-- --></p>
</div>
<div id="case-control-design" class="section level3">
<h3>Case-control design</h3>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">cc.fit &lt;-<span class="st"> </span>binary.cc +<span class="st"> </span><span class="kw">integrate_parametric</span>(S<span class="fl">.1</span> ~<span class="st"> </span>BIP) +<span class="st"> </span>
<span class="st">  </span><span class="kw">risk_binary</span>(<span class="dt">D =</span> <span class="dv">10</span>) +<span class="st"> </span><span class="kw">ps_estimate</span>()
cc.fit</code></pre></div>
<pre><code>## Augmented data frame:  500  obs. by  6  variables. 
##   Z Y    S.1   S.0 cdfweights    BIP
## 1 1 1 -0.449    NA        1.0 -1.375
## 2 1 0     NA    NA        0.2  1.749
## 3 1 0     NA    NA        0.2 -0.791
## 4 0 1     NA -1.06        1.0 -0.879
## 5 1 0     NA    NA        0.2 -0.709
## 6 0 0     NA    NA        0.2 -1.508
## 
## Empirical VE:  0.548 
## 
## Mapped variables: 
##   Z  -&gt;  Z 
##   Y  -&gt;  Y.obs 
##   S  -&gt;  S.obs 
##   BIP  -&gt;  BIP 
##   weights  -&gt;  weights 
## 
## Integration models: 
##   integration model for  S.1 :
##       integrate_parametric(formula = S.1 ~ BIP )
## 
## Risk models: 
##   risk_binary(D = 10 )
## 
## Estimated parameters:
## (Intercept)         S.1           Z       S.1:Z 
##     -1.0279      0.0381     -0.1918     -1.4115 
##  Convergence:  TRUE 
## 
##  No bootstraps present, see ?ps_bootstrap.</code></pre>
</div>
<div id="survival-outcome" class="section level3">
<h3>Survival outcome</h3>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">surv.fit &lt;-<span class="st"> </span><span class="kw">psdesign</span>(fakedata, <span class="dt">Z =</span> Z, <span class="dt">Y =</span> <span class="kw">Surv</span>(time.obs, event.obs), 
                     <span class="dt">S =</span> S.obs, <span class="dt">BIP =</span> BIP, <span class="dt">CPV =</span> CPV) +<span class="st"> </span>
<span class="st">  </span><span class="kw">integrate_semiparametric</span>(<span class="dt">formula.location =</span> S<span class="fl">.1</span> ~<span class="st"> </span>BIP, <span class="dt">formula.scale =</span> S<span class="fl">.1</span> ~<span class="st"> </span><span class="dv">1</span>) +<span class="st"> </span>
<span class="st">  </span><span class="kw">risk_exponential</span>(<span class="dt">D =</span> <span class="dv">10</span>) +<span class="st"> </span><span class="kw">ps_estimate</span>(<span class="dt">method =</span> <span class="st">&quot;BFGS&quot;</span>) +<span class="st"> </span><span class="kw">ps_bootstrap</span>(<span class="dt">n.boots =</span> <span class="dv">20</span>)</code></pre></div>
<pre><code>## Warning in psdesign(fakedata, Z = Z, Y = Surv(time.obs, event.obs), S
## = S.obs, : tau missing in psdesign: assuming that the surrogate S was
## measured at time 0.</code></pre>
<pre><code>## Bootstrapping 20 replicates:
## ===========================================================================</code></pre>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">surv.fit</code></pre></div>
<pre><code>## Augmented data frame:  500  obs. by  7  variables. 
##   Z           Y     S.1   S.0 cdfweights    BIP    CPV
## 1 1 0.05371734+ -0.4486    NA          1 -1.375     NA
## 2 1 0.02635337   2.5169    NA          1  1.749     NA
## 3 1 0.52200085   0.1627    NA          1 -0.791     NA
## 4 0 0.23835140       NA -1.06          1 -0.879     NA
## 5 1 0.02961862   0.0885    NA          1 -0.709     NA
## 6 0 0.13822338       NA -1.65          1 -1.508 -0.325
## 
## Empirical VE:  -0.384 
## 
## Mapped variables: 
##   Z  -&gt;  Z 
##   Y  -&gt;  Surv(time.obs, event.obs) 
##   S  -&gt;  S.obs 
##   BIP  -&gt;  BIP 
##   CPV  -&gt;  CPV 
## 
## Integration models: 
##   integration model for  S.1 :
##       integrate_semiparametric(formula.location = S.1 ~ BIP, formula.scale = S.1 ~ 1 )
## 
## Risk models: 
##   risk_exponential(D = 10 )
## 
## Estimated parameters:
## (Intercept)         S.1           Z       S.1:Z 
##     -0.8732      0.0378     -0.0997     -1.1377 
##  Convergence:  TRUE 
## 
## Bootstrap replicates:
##             boot.se lower.CL.2.5% upper.CL.97.5%
## (Intercept)  0.0657       -0.9995        -0.7918
## S.1          0.0613       -0.0755         0.1129
## Z            0.1180       -0.3150         0.0736
## S.1:Z        0.1001       -1.2705        -0.9292
## 
##   Out of 20 bootstraps,  20 converged ( 100 %)
## 
##   Test for wide effect modification on 1 degree of freedom. 2-sided p value  &lt; .0001</code></pre>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">plot</span>(surv.fit, <span class="dt">t =</span> .<span class="dv">4</span>)</code></pre></div>
<p><img src="data:image/png;base64,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" alt /><!-- --></p>
</div>
<div id="categorical-s" class="section level3">
<h3>Categorical S</h3>
<p><code>S.obs.cat</code> and <code>BIP.cat</code> are factors:</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">with</span>(fakedata, <span class="kw">table</span>(S.obs.cat, BIP.cat))</code></pre></div>
<pre><code>##                BIP.cat
## S.obs.cat       (-Inf,-0.688] (-0.688,-0.0207] (-0.0207,0.663]
##   (-Inf,-0.226]            88               37               0
##   (-0.226,0.45]            36               45              44
##   (0.45,1.24]               1               43              48
##   (1.24, Inf]               0                0              33
##                BIP.cat
## S.obs.cat       (0.663, Inf]
##   (-Inf,-0.226]            0
##   (-0.226,0.45]            0
##   (0.45,1.24]             33
##   (1.24, Inf]             92</code></pre>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">cat.fit &lt;-<span class="st"> </span><span class="kw">psdesign</span>(fakedata, <span class="dt">Z =</span> Z, <span class="dt">Y =</span> Y.obs, 
                     <span class="dt">S =</span> S.obs.cat, <span class="dt">BIP =</span> BIP.cat) +<span class="st"> </span>
<span class="st">  </span><span class="kw">integrate_nonparametric</span>(<span class="dt">formula =</span> S<span class="fl">.1</span> ~<span class="st"> </span>BIP) +<span class="st"> </span>
<span class="st">  </span><span class="kw">risk_binary</span>(Y ~<span class="st"> </span>S<span class="fl">.1</span> *<span class="st"> </span>Z, <span class="dt">D =</span> <span class="dv">10</span>, <span class="dt">risk =</span> risk.probit) +<span class="st"> </span><span class="kw">ps_estimate</span>(<span class="dt">method =</span> <span class="st">&quot;pseudo-score&quot;</span>)
cat.fit</code></pre></div>
<pre><code>## Augmented data frame:  500  obs. by  6  variables. 
##   Z Y           S.1           S.0 cdfweights           BIP
## 1 1 1 (-Inf,-0.226]          &lt;NA&gt;          1 (-Inf,-0.688]
## 2 1 0   (1.24, Inf]          &lt;NA&gt;          1  (0.663, Inf]
## 3 1 0 (-0.226,0.45]          &lt;NA&gt;          1 (-Inf,-0.688]
## 4 0 1          &lt;NA&gt; (-Inf,-0.226]          1 (-Inf,-0.688]
## 5 1 0 (-0.226,0.45]          &lt;NA&gt;          1 (-Inf,-0.688]
## 6 0 0          &lt;NA&gt; (-Inf,-0.226]          1 (-Inf,-0.688]
## 
## Empirical VE:  0.548 
## 
## Mapped variables: 
##   Z  -&gt;  Z 
##   Y  -&gt;  Y.obs 
##   S  -&gt;  S.obs.cat 
##   BIP  -&gt;  BIP.cat 
## 
## Integration models: 
##   integration model for  S.1 :
##       integrate_nonparametric(formula = S.1 ~ BIP )
## 
## Risk models: 
##   risk_binary(model = Y ~ S.1 * Z, D = 10, risk = risk.probit )
## 
## Estimated parameters:
##        (Intercept)   S.1(-0.226,0.45]     S.1(0.45,1.24] 
##            -0.6612             0.0781             0.1461 
##     S.1(1.24, Inf]                  Z S.1(-0.226,0.45]:Z 
##            -0.0361             0.6180            -1.0023 
##   S.1(0.45,1.24]:Z   S.1(1.24, Inf]:Z 
##            -1.5899            -1.7880 
##  Convergence:  TRUE 
## 
##  No bootstraps present, see ?ps_bootstrap.</code></pre>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">plot</span>(cat.fit)</code></pre></div>
<p><img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAqAAAAHgCAMAAABNUi8GAAAAVFBMVEUAAAAAADoAAGYAOpAAZrY6AAA6ADo6AGY6Ojo6ZrY6kNtmAABmtrZmtv+QOgCQZgCQ2/+2ZgC2Zjq2/7a2///bkDrb////tmb/25D//7b//9v///8ZQNTEAAAACXBIWXMAAA7DAAAOwwHHb6hkAAALh0lEQVR4nO3daUPb2AGGUYWQtgOFQieOAf///1lr84YXWQt+i875kBhQdK+tZ2RJ9uBiBcGKW08AzhEo0QRKNIESTaBEEyjRBEo0gRJNoEQTKNEESjSBEk2gRBMo0QRKNIESTaBEEyjRBEo0gRJNoEQTKNEESjSBEk2gRBMo0QRKNIESTaBEEyjRBEo0gRJNoEQTKNEESjSBEk2gRBMo0QRKNIESTaBEEyjRBEo0gRJNoEQTKNEESjSBEk2gRBMo0QRKNIESTaBEEyjRBEo0gRJNoEQTKNEESjSBEk2gRBMo0QRKNIESTaBEEyjRBEo0gRJNoEQTKNEESjSBEk2gRBMo0QRKNIESTaBEGznQAjq5VaDjro7vSqBEEyjRBEo0gRJNoEQTKNEESjSBEk2gHJXyOpFAOeqLAr3YgUA5KqRPgZJNoEQTKNEESjSBEk2gRBMo0QRKNIESTaBEEyjRBEo0gRJNoKFS3k10awIN9UWBxm8HgYbSZ02gRBMo0QRKNIESTaBEEyjRBEo0gRJNoEQTKNEESjSBEk2gRBMo0QRKNIESTaBEEyjRBEo0gRJNoEQTKNEESjSBEk2gRBMo0QRKNIESTaBEEyjRBEo0gRJtkkDfHx/Wfy6Lorj7PcLqmLHpAl38/FPeehq+OmZsskCbNKtMB66OGZss0LdfVaDLE0/yAqUTe1CiTRRo+QES96v2dGng6pixqS4zrRv98bI+kT/Rp0DpxnVQogmUaFMHunAWzxBfvAf9P/oMPiJ4iieaQIk2UaAfz/UTuTeLMMw0gS7a658nL4QKlE4mCfTjeZOllzoZZKKXOjdvsvNmEQaxByXaVMegzS7UMSjDTHQWX7+fqShO7D8FSkeugxJNoEQTKNEESjSBnlB8jVvfzXgCPeGLAo1/HG5NoCfoM4NAiSZQogmUaAIlmkCJJlCiCZRoAiWaQIkmUKIJlGgCJZpAiSZQogmUaAIlmkCJJlCiCZRoAiWaQIkmUKIJlGgCJZpAiSZQogmUaAIlmkCJJlCiCZRoAiWaQIkmUKIJlGgCJZpAiSZQogmUaAIlmkCJJlCiCZRoAiWaQIkmUKIJlGgCJZpAiSZQogmUaAIl2kSBfjwXlbvfo6yO2Zom0EXxUN9YtjcGrY75ujLQ98en9hvLk3vH9f5zk+Xi559h4zJvfQKt+zsTaIeMBUonkwRqD8pYJgl0fQza7EIdgzLMNIGul6vP4k/sPwVKRxMFOt64zJtAiTZ1oAtn8QxxdaDFRp896PZfX/9vmSOvxROt/ytJXzQu89bjKf6+w9LeLMI4rn6KL9P78XJhYW8WYSR9jkHL3eiJ7mpe6mQsPU+SlmdP4r1ZhLH0P4v3ZhG+QP896MmX2VfeLMJoJjkG9WYRxjLNWfyI4zJvE10HHW9c5s0rSUTzWjzRBEo0gRJNoEQTKNEESjSBEk2gRBMo0QRKNIESTaBEEyjRBEo0gRJNoEQTKNEESjSBEk2gRBMo0QRKNIESTaBEEyjRBEo0gRJNoEQTKNEESjSBEk2gRBMo0QRKNIESTaBEEyjRBEo0gRJNoEQTKNEESjSBEk2gRBMo0QRKNIESTaBEEyjRBEo0gRJNoEQTKNEESrRJAn1/fFj/uSyK4u73CKtjxqYLdPHzT3nrafjqmLHJAm3SrDIduDpmbLJA335VgS5PPMkLlE7sQYk2UaDr86PiftWeLg1cHTM21WWmdaM/XtYn8if6FCjduA5KNIESbepAF87iGcIelGgCJdoXB1psjLI6vr2JAv14rjP0ZhGGmSbQRXv98+SFUIHSySSBfjxvsvRSJ4NM9FLn5k123izCIPagRJvqGLTZhToGZZiJzuLr9zMVxYn9p0DpyIV6ok0Z6M6h6BirY44ESjSBEk2gRBMo0ZzFE02gRBMo0QRKNIESTaBEEyjRBEo0gRJNoEQTKNEESjSBEk2gRBMo0QRKNIESTaBEEyjRBEo0gRJNoEQTKNEESjSBEk2gRBMo0QRKNIESTaBEEyjRBEo0gRJNoEQTKNEESjSBEk2gRBMo0QRKNIESTaBEEyjRBEo0gRJNoEQTKNEESrTYQIuvMe69YnRzD1Sh4eYe6Lj3itHFBgolgRJNoEQTKNEESjSBEk2gRBMo0QRKNIES7WaBQic3CnQSt56j8ec6eEe3nqPx5zp4R7eeo/HnOnhHt56j8ec6eEe3nqPx5zp4R7eeo/HnOnhHt56j8ec6eEe3nqPx5zp4R7eeo/HnOjhcIlCiCZRoAiWaQIkmUKIJlGgCJZpAiSZQogmUaAIlmkCJduNAP56fqr+XP14231sUxcN2iWVRbH728VzUP9vcWL39Kor78uudFVw1cscRjixbev35Z7V6fyz/P9r7HpNopnFurZtvvv3z9+Ekm2V7Dfx5FueG2Cx5sKGKoSNfdONAF80G2Lnf7487eVY/aH/48by+sah6bG6sluvH7v3xfv+Bu2rkziMcLlt9XZTb7u0fL5/uxTXTuLDW2vvjXVPPdm6bZXsM/GkWF4Zo53awoYaOfNFtA31/bHZje/f7abvAx3NZ62v9SL39Kn+yuPu9uVH/eH3j6gdqM0rnEQ6XrVZS59Fu1+u3VjmNS2utV10U7debue0sOyyT+sE4P0Q7j4MN9c0D3d2074//Xj+pPZXPqNtNs/tIrTaLbm5s9zLXPlDLY9vi7AhHll38/E+57fZ2xtcpp3FprdVyxcN+sM1YzbIDM6lWfWGI7ff2NtQ3D/R1Z9O+P5ZPK+XfO3vQuo+9B+61/WJ9Y3n392N9rHTtA7UZufMIn5ddf1kdnr3+q+g3iXoal9baOKinmmS77MBM2gfj3BDtLA421PcOdHu4Wd3vh2oftRdoff/3D9AetjcW5c724/n6Y9C9kbuN8GnZ8qn5tTpCrXrqc0C2cxh3eq3ttA6e8h+2yw7MZPNgnBui/ebBhvrugW7OpJv/INd/nA902Z7XVjcWP9qdz9WB7ozcbYRPyy7W22277XpMYu8w7vRaP99sJ7lZdmig7ZnAmSHa7x5sqO8daH30VToV6OET8N7erT1wK1dz5QO1HbnzCIfLVl9st12PSTTrvbTWdmI79dRz2y47LJPNIOeGaL89q0Cru1heTXs4Emj1/YMTiEVbT3OjfkTLR7HPHvS6EVYHJ0mL5vcINhu3xySaaVxaa2OnnmZu22XH34N+GqKdxcwC3TsGPbIH3b8Es2gfqPZGc32kz1N8O3LnET4tWyp3LnVgPZ/iHy6vtbG9uSie9pcd/xj08xDtLGYV6MFZ/JFA9y5iv/1qz6bbG9UhUrWBe5/Fdx7hcNl6NdWZTLmuXidJ9T+9sNZ2ntsLY7uvZExyFn9kiHYW8wp0/zro9n63p82r6kmmfAzK7zTPNz9eNjeqq8u9rvDsPZt1GaGe0s6ylXrbvTZPgv2ug15Y6+YSQrno3iS3y45xHfT8EDsXMuYU6P7ecsfbX1euqfcrSZ11mFK/V5JuMvBYs/jmge6/XLJj+XD8+yf1fy2+8wiXp9TztfibDDzSLL57oNv3FO3773V3e9C7mTq6OKX+72a6xcCjzGL4yBd5PyjRBEo0gRJNoEQTKNEESjSBEk2gRBMo0QRKNIESTaBEEyjRBEo0gRJNoEQTKNEESjSBEk2gRBMo0QRKNIESTaBEE+hUqo+R2f2NsNsPeaE7gU5kWf06sdfdD8W4E+j1BDqR+lcabn9N33J/d0pHAp3Gzi+QrHz+kBc6EehElsXhb4wTaB8Cncr+J5KtBNqPQCe0/9sJBdqHQKf1euxTEOhOoNNoP3to9xPCBNqDQKex99EHq8ObdCbQiTQf5F4c+RwZriDQqVQvde5+uoxA+xAo0QRKNIESTaBEEyjRBEo0gRJNoEQTKNEESjSBEk2gRBMo0QRKNIESTaBEEyjRBEo0gRJNoEQTKNEESjSBEk2gRPsf53UlQbLd9XUAAAAASUVORK5CYII=" alt /><!-- --></p>
</div>
<div id="pseudo-score" class="section level3">
<h3>Pseudo-score</h3>
<p>Categorical W allows for estimation of the model using the pseudo-score method. <span class="math inline">\(S\)</span> may be continuous or categorical:</p>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r">cat.fit.ps &lt;-<span class="st"> </span><span class="kw">psdesign</span>(fakedata, <span class="dt">Z =</span> Z, <span class="dt">Y =</span> Y.obs, 
                     <span class="dt">S =</span> S.obs, <span class="dt">BIP =</span> BIP.cat) +<span class="st"> </span>
<span class="st">  </span><span class="kw">integrate_nonparametric</span>(<span class="dt">formula =</span> S<span class="fl">.1</span> ~<span class="st"> </span>BIP) +<span class="st"> </span>
<span class="st">  </span><span class="kw">risk_binary</span>(Y ~<span class="st"> </span>S<span class="fl">.1</span> *<span class="st"> </span>Z, <span class="dt">D =</span> <span class="dv">10</span>, <span class="dt">risk =</span> risk.logit) +<span class="st"> </span><span class="kw">ps_estimate</span>(<span class="dt">method =</span> <span class="st">&quot;pseudo-score&quot;</span>) +<span class="st"> </span>
<span class="st">  </span><span class="kw">ps_bootstrap</span>(<span class="dt">n.boots =</span> <span class="dv">20</span>, <span class="dt">method =</span> <span class="st">&quot;pseudo-score&quot;</span>)</code></pre></div>
<pre><code>## Bootstrapping 20 replicates:
## ===========================================================================</code></pre>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">summary</span>(cat.fit.ps)</code></pre></div>
<pre><code>## Augmented data frame:  500  obs. by  6  variables. 
##   Z Y     S.1   S.0 cdfweights           BIP
## 1 1 1 -0.4486    NA          1 (-Inf,-0.688]
## 2 1 0  2.5169    NA          1  (0.663, Inf]
## 3 1 0  0.1627    NA          1 (-Inf,-0.688]
## 4 0 1      NA -1.06          1 (-Inf,-0.688]
## 5 1 0  0.0885    NA          1 (-Inf,-0.688]
## 6 0 0      NA -1.65          1 (-Inf,-0.688]
## 
## Empirical VE:  0.548 
## 
## Mapped variables: 
##   Z  -&gt;  Z 
##   Y  -&gt;  Y.obs 
##   S  -&gt;  S.obs 
##   BIP  -&gt;  BIP.cat 
## 
## Integration models: 
##   integration model for  S.1 :
##       integrate_nonparametric(formula = S.1 ~ BIP )
## 
## Risk models: 
##   risk_binary(model = Y ~ S.1 * Z, D = 10, risk = risk.logit )
## 
## Estimated parameters:
## (Intercept)         S.1           Z       S.1:Z 
##     -0.9211     -0.0718     -0.3294     -1.2760 
##  Convergence:  TRUE 
## 
## Bootstrap replicates:
##             boot.se lower.CL.2.5% upper.CL.97.5%
## (Intercept)   0.227        -1.211         -0.510
## S.1           0.157        -0.331          0.176
## Z             0.321        -0.817          0.290
## S.1:Z         0.427        -2.113         -0.626
## 
##   Out of 20 bootstraps,  20 converged ( 100 %)
## 
##   Test for wide effect modification on 1 degree of freedom. 2-sided p value  = 0.0028 
## 
## Vaccine Efficacy: 
## empirical  marginal     model 
##     0.548     0.548     0.559 
##  Model-based average VE is 1.9 % different from the empirical and 1.9 % different from the marginal.</code></pre>
<div class="sourceCode"><pre class="sourceCode r"><code class="sourceCode r"><span class="kw">plot</span>(cat.fit.ps)</code></pre></div>
<p><img src="data:image/png;base64,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" alt /><!-- --></p>
</div>
</div>
</div>
<div id="bug-reports" class="section level1">
<h1>Bug reports</h1>
<ul>
<li>File bugs and suggestions here as a <a href="https://github.com/sachsmc/pseval/issues">github issue</a></li>
</ul>
</div>
<div id="references" class="section level1 unnumbered">
<h1>References</h1>
<div id="refs" class="references">
<div id="ref-Follmann06">
<p>Follmann, D. 2006. “Augmented Designs to Assess Immune Response in Vaccine Trials.” <em>Biometrics</em> 62 (4): 1161–9.</p>
</div>
<div id="ref-Frangakis02">
<p>Frangakis, CE, and DB Rubin. 2002. “Principal Stratification in Causal Inference.” <em>Biometrics</em> 58 (1): 21–29.</p>
</div>
<div id="ref-Gabriel15b">
<p>Gabriel, Erin E, and Dean Follmann. 2015. “Augmented Trial Designs for Evaluation of Principal Surrogates.” <em>Biostatistics</em> 0 (0): 1–25.</p>
</div>
<div id="ref-Gabriel14">
<p>Gabriel, Erin E., and Peter B. Gilbert. 2014. “Evaluating Principal Surrogate Endpoints with Time-to-Event Data Accounting for Time-Varying Treatment Efficacy.” <em>Biostatistics</em> 15 (2): 251–65.</p>
</div>
<div id="ref-Gabriel15">
<p>Gabriel, Erin E., Michael C. Sachs, and Peter B. Gilbert. 2015. “Comparing and Combining Biomarkers as Principle Surrogates for Time-to-Event Clinical Endpoints.” <em>Statistics in Medicine</em> 34 (3): 381–95. doi:<a href="https://doi.org/10.1002/sim.6349">10.1002/sim.6349</a>.</p>
</div>
<div id="ref-Gilbert08">
<p>Gilbert, PB, and MG Hudgens. 2008. “Evaluating Candidate Principal Surrogate Endpoints.” <em>Biometrics</em> 64 (4): 1146–54.</p>
</div>
<div id="ref-Huang11">
<p>Huang, Y, and PB Gilbert. 2011. “Comparing Biomarkers as Principal Surrogate Endpoints.” <em>Biometrics</em>.</p>
</div>
<div id="ref-Huang12">
<p>Huang, Ying, Peter B Gilbert, and Julian Wolfson. 2013. “Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials.” <em>Biometrics</em> 69 (2): 301–9.</p>
</div>
<div id="ref-Pepe91">
<p>Pepe, MS, and TR Fleming. 1991. “A Nonparametric Method for Dealing with Mismeasured Covariate Data.” <em>Journal of the American Statistical Association</em> 86 (413): 108–13.</p>
</div>
<div id="ref-WolfsonDiss">
<p>Wolfson, J. 2009. “Statistical Methods for Identifying Surrogate Endpoints in Vaccine Trails.” Doctor of Philosophy Dissertation, Chair: Gilbert, Peter: University of Washington; Department of Biostatistics.</p>
</div>
<div id="ref-Wolfson10">
<p>Wolfson, J, and PB Gilbert. 2010. “Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials.” <em>Biometrics</em> 66 (4): 1153–61.</p>
</div>
</div>
</div>



<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
